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ABSTRACT 
 
Background  The current obstetric ultrasound service in the Tygerberg 
hospital (TBH) drainage area provides only routine early scans with follow-up for 
selective clinical indications. Patients who book at and after 24 weeks gestational 
age do not receive an ultrasound unless clinically indicated. Therefore fetal 
abnormalities and or pregnancy complications in this group could go undetected. 
 
Aims The primary aim of the study was to compare 2 ultrasound referral 
protocols in respect of the number of clinically relevant abnormalities detected 
prior to delivery and their gestational age (GA) at diagnosis: 
 The current protocol of routine early ultrasound scans (18 – 23 weeks) 
and scans for selective clinical indications (Control Group/ Group A) 
 The new protocol of booking scans for all, regardless of GA, and follow-up 
for selective clinical indications protocol (Study Group/ Group B). 
Secondary aims of the study were: 
 To compare the number of patients receiving an ultrasound and the total 
number of scans performed in each group, including all follow-up scans. 
 To compare the number of patients receiving an ultrasound between 18 
and 23 weeks GA since this is regarded as the most appropriate for a 
detailed scan. 
 To calculate and compare the percentages of (presumed) postdates or 
preterm pregnancies and small for gestational age (SGA) babies between 
both groups. 
 To determine which of the three dating methods (ultrasound, last 
menstrual period (LMP) dates and fundal height (FH) measurements) 
estimates the date of delivery most accurately. 
 To determining the influence of the body mass index (BMI) on the 
accuracy of GA estimation by means of a FH measurement. 
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 To obtain more accurate data on booking tendencies by calculating the 
GA at booking, confirmed by ultrasound. 
 
Methods An analytical audit was done on a low-risk population attending 2 
public sector antenatal care facilities in the Cape Town metropolitan area. Firstly 
the audit was done with the current, routine early ultrasound and selective 
referral protocol for specific clinical indications in place. Following this audit the 
ultrasound protocol was changed to a booking scan and selective referral 
protocol for specific clinical indications and another audit was done. The study 
followed a participatory action research model. Seven hundred and fifty 
consecutive patients were recruited into each group. 
 
Results There were 631 (84.1%) patients in Group A and 629 (83.9%) 
patients in Group B with known pregnancy outcome. The two groups were 
comparable with regard to age, gravidity, parity, mean birth weight (BW), number 
of low BW cases and cases of intra-uterine death. Although the two groups 
differed significantly in the median 5 minute Apgar scores (p = 0.001), the 
difference was concluded to be of no clinical significance. No difference was 
found in the number of cases with Apgar scores below 7 (p = 0.12). 
 
A significant difference was found between the groups with regard to the number 
of complications and abnormalities detected antenatally with ultrasound [p = 0.02 
OR (95%CI): 0.62(0.41 - 0.94)]. This is mainly due to significantly more early fetal 
loss cases detected in Group B [p = 0.03 OR (95%CI): 0.12 (0.01 – 0.96)]. There 
was however no difference between the number of congenital fetal abnormalities 
(p = 0.33), twin pregnancies (p = 0.53) and the number of early low lying 
placentas (p = 0.41). 
 
The two groups were comparable with regard to the number of abnormalities and 
complications at birth (p = 0.29) even though 93.7% of cases with abnormalities 
or complications at birth had a scan in Group B as opposed to the 62.3% of 
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cases in Group A. In total, three cases with fetal abnormalities were overlooked 
at Bishop Lavis Community Health Centre. 
 
No difference was found between the groups with regard to the number of 
congenital fetal abnormalities (8 vs 6, p = 0.79), the number (5 vs 12, p = 0.14) or 
mean GA at diagnosis (21w4d vs 18w4d, p = 0.30) of twin pregnancies or the 
number of cases with placenta praevia at 32 weeks (1 vs 1), detected with 
ultrasound. Combining these complications also yielded no difference between 
the groups with regard to the number of complications (14 vs 19, p = 0.47) nor 
the mean GA at diagnosis (22w4d vs 19w1d, p = 0.07). 
 
Significant differences between groups A and B were shown in the median (1 vs 
1, p < 0.001) and average (0.81 vs 1.41) number of scans performed per patient. 
Differences were also shown in the number of scans performed between 18 
weeks 0 days and 23 weeks 6 days [330 vs 382, p = 0.003 OR (95%CI): 0.71 
(0.56 – 0.89)], the number of scans performed prior to 24 weeks GA [336 vs 412, 
p < 0.001 OR (95%CI): 0.60 (0.47 – 0.76)] and the number of patients receiving 
at least one scan [390 vs 567, p < 0.001 OR (95%CI) 0.18 (0.13 – 0.24)]. A 74% 
increased workload was observed with Group B. 
 
A significant difference was found when comparing the groups with regard to the 
number of requested follow-up ultrasound examinations by the ultrasound 
departments [105 vs 313, p < 0.001 OR (95%CI): 0.20 (0.15 – 0.26)]. This was 
mainly due to the significant increase in requested follow-up examinations for 
fetal detail in Group B [42 vs 212, p < 0.001 OR (95%CI): 0.32 (0.20 – 0.51)] and 
is also responsible for the significant differences found in the number of requests 
for follow-up for possible fetal abnormality [14 vs 11, p < 0.001 OR (95%CI): 4.22 
(1.73 – 10.38)] fetal growth and Doppler [29 vs 54, p = 0.03 OR (95%CI): 1.83 
(1.05 – 3.17)] and placenta localization at 32 weeks GA [10 vs 10, p = 0.02 OR 
(95%CI): 3.19 (1.19 – 8.58)]. 
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The two groups were comparable for all clinical reasons for ultrasound referrals 
(p = 0.60). The change in referral protocol for certain high risk patients from TBH 
to Karl Bremer hospital on the 1st of July 2008 did not have a negative effect on 
the study as the number of patients delivering at Elsiesriver Midwife Obstetric 
Unit remained unchanged (p = 0.23). No difference was found between the 
groups with regard to all types of labour and modes of delivery. 
 
No difference was found between the groups in the number of preterm deliveries 
(p = 0.64) and SGA babies (p = 0.42). A significant difference was found with 
regard to the number of postdates deliveries [p = 0.01 OR (95%CI): 1.64 (1.11 – 
2.41)]. When combining these complications related to the accurate dating of 
pregnancies, no difference was found (p = 0.50). In order to determine the impact 
of ultrasound at and after 24 weeks GA the number of patients who did not 
receive an ultrasound in Group A was compared to the number of patients in 
Group B who received an ultrasound at and after 24 weeks GA. No difference 
was found with regard to the preterm deliveries (p = 0.30) and SGA babies 
(p = 0.86). A significant difference was found in the postdates pregnancy 
category [p = 0.001 OR (95%CI): 2.28 (1.34 – 3.89)] and when these 
complications were combined [p = 0.003 OR (95%CI): 1.65 (1.17 – 2.31)]. 
 
Comparing the 3 pregnancy dating methods (ultrasound, LMP dates and FH 
measurements), revealed that ultrasound predicted the estimated due date within 
10 days in 89.8% of cases in comparison to the 66.5% predicted by using the 
LMP dates and the 54.6% predicted by using the FH measurements. Significant 
differences were found when ultrasound was compared to LMP (p < 0.001), 
ultrasound compared to FH (p < 0.001) and LMP compared to FH (p = 0.01). 
 
The mean BMI of Group A was found to be significantly (p = 0.004) less than the 
mean BMI observed for Group B. This was concluded to be of no clinical 
significance. Data from the two groups were combined in the calculation to 
determine the impact of BMI on FH measurements. All patients who received an 
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ultrasound and had a known FH measurement were included in the calculation. 
Ultrasound was set to naught and the difference in weeks between GA as 
determined by ultrasound and FH was determined. With a BMI of up to 
39.9kg/m2, GA as determined by ultrasound and FH agreed within 3 weeks in 75 
to 80% of cases. With a BMI of 40kg/m2 and over the agreement within 3 weeks 
decreased to less than 46% of cases. 
 
In Group B, 444 patients (78.2%) attended their ultrasound appointment within 7 
days of booking. Of these 23.4% were found to be less than 18 weeks, 42.3% 
between 18 weeks 0 days and 23 weeks 6 days and 34.2% were at and over 24 
weeks GA. Therefore, 65.7% of patients were eligible for a detail scan. In this 
group the clinically determined GA prior to ultrasound agreed within 2 weeks and 
3 weeks with the GA as determined with ultrasound in 69.6% and 82.8% of cases 
respectively. 
 
Conclusions In this population only approximately 34% of patients 
benefited from the booking scan protocol. This protocol would probably be better 
suited for a population with a higher percentage of patients booking at and after 
24 weeks GA. The booking scan protocol increased the workload significantly 
with no significant benefits except for the reduced number of postdates 
pregnancies. 
 
A booking scan is also recommended for all patients with body mass indexes of 
40 or greater as the GA as determined by fundal height and ultrasound 
correlated within 3 weeks in less than 50%. A travelling ultrasound service will 
aid in improving the attendance rate in a population that is in general socio-
economically deprived. 
 
A combination of both protocols is likely to be more cost-effective: patients 
booking with a FH of less than 26 cm are scheduled for a detail scan between 18 
and 24 weeks clinically estimated GA while patients booking later than this 
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(either all of them or at least those with a BMI of 40 kg/m2 or more) are scanned 
as soon as possible after booking. This protocol would probably still demonstrate 
the benefit of reduced postdates pregnancies while significantly reducing the total 
workload. This could be the topic of a subsequent study. 
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ABSTRAK 
 
Agtergrond  Die huidige obstetriese sonar diens in die Tygerberg hospital 
(TBH) dreineringsarea voorsien slegs roetine vroeë sonars met opvolg vir 
selektiewe kliniese indikasies. Pasiënte wat na 24 weke gestasie ouderdom 
bespreek ontvang slegs ‘n sonar indien dit klinies aangedui is. Fetale 
abnormaliteite en of komplikasies van swangerskap in hierdie groep kan 
ongediagnoseerd bly. 
 
Doelwitte Die primêre doelwit van die studie was om 2 sonar verwysings 
protokolle te vergelyk ten opsigte van die hoeveelheid klinies relevante 
abnormaliteite geïdentifiseer voor geboorte en die gestasie met diagnose: 
 Die huidige roetine vroeë sonar (18 – 23 weke) protokol en sonars vir 
selektiewe kliniese indikasies (Groep A). 
 Die nuwe besprekings sonar vir almal protokol, onafhanklik van gestasie 
en opvolg vir selektiewe kliniese indikasies (Group B). 
Sekondêre doelwitte van die studie was: 
 Om die hoeveelheid pasiënte wat ‘n sonar ontvang het te vergelyk asook 
die totale hoeveelheid sonars wat gedoen is in elke groep insluitend die 
opvolg ondersoeke. 
 Om ‘n vergelyking te tref tussen die hoeveelheid pasiënte wat ‘n sonar 
ontvang het tussen 18 en 23 weke gestasie sienende dat hierdie tydsgleuf 
as die mees ideale tyd vir ‘n detail sonar geag word. 
 Om die persentasies van vermoedelike post-mature en pre-mature 
swangerskappe asook klein vir gestasie babas te bepaal en te vergelyk 
tussen die 2 groepe. 
 Om te bepaal watter een van die 3 gestasie bepalende metodes (sonar, 
laaste menstruele periode (LMP) datums en fundale hoogte (FH) mates) 
die datum van verlossing die beste voorspel. 
 Om te bepaal wat die invloed is van die liggaams massa indeks (BMI) op 
die akkuraatheid van gestasie bepaling deur middel van die FH mate. 
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 Die verkryging van meer akkurate inligting oor die besprekings neigings 
deur die gestasie by bespreking te bepaal, bevestig met sonar. 
 
Metodes ‘n Analitiese oudit was gedoen op ‘n lae risiko populasie wat 
voorgeboorte sorg ontvang by 2 publieke sektor fasiliteite in die Kaapstad 
metropolitaanse area. Die oudit was eers gedoen met die huidige roetine vroeë 
sonar en selektiewe verwysings protocol vir spesifieke kliniese indikasies in plek. 
Dit was gevolg deur ‘n verandering in die protokol na ‘n besprekings sonar en 
selektiewe verwysings protokol vir spesifieke kliniese indikasies en nog ‘n oudit is 
gedoen. Die studie het ‘n deelnemings aksie navorsings model gevolg. Sewe 
honderd en vyftig opeenvolgende pasiënte was gewerf vir elke groep in die 
studie. 
 
Resultate Daar was 631 (84.1%) pasiënte in Groep A en 629 (83.9%) 
pasiënte in Groep B waarvan die swangerskapsuitkomste bekend was. Die twee 
groepe was vergelykbaar in terme van ouderdom, graviditiet, pariteit, gemiddelde 
geboortegewig, hoeveelheid lae geboortegewig en intra-uteriene sterfgevalle. 
Alhoewel die twee groepe betekenisvol verskil het in die mediaan 5 minute Apgar 
tellings (p = 0.001), was die verskil bevind om van geen kliniese belang te wees 
nie. Geen verskil was gevind in die hoeveelheid gevalle met Apgar tellings onder 
7 nie (p = 0.12). 
 
‘n Betekenisvolle verskil was gevind tussen die groepe met betrekking tot die 
hoeveelheid komplikasies en abnormaliteite wat opgespoor is voor geboorte met 
sonar [p = 0.02 OR (95%CI): 0.62(0.41 - 0.94)]. Dit is hoofsaaklik as gevolg van 
die betekenisvolle meer vroeë fetale verliese wat opgespoor is in Groep B 
[p = 0.03 OR (95%CI): 0.12 (0.01 – 0.96)]. Daar was geen verskil gevind tussen 
die hoeveelheid kongenitale fetale abnormaliteite (p = 0.33), tweeling 
swangerskappe (p = 0.53) en die hoeveelheid vroeë laag liggende plasentas (p = 
0.41) nie. 
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Die twee groepe was vergelykbaar in die hoeveelheid abnormaliteite en 
komplikasies by geboorte (p = 0.29) ten spyte daarvan dat 93.7% van gevalle 
met abnormaliteite en komplikasies by geboorte ‘n sonar gehad het in Groep B in 
teenstelling met die 62.3% van gevalle in Groep A. In totaal was 3 fetale 
abnormaliteite oorgesien by die Bishop Lavis Gemeenskaps Gesondheid 
Sentrum. 
 
Geen verskil was gevind tussen die groepe in die hoeveelheid kongenitale fetale 
abnormaliteite (8 teen 6, p = 0.79), die hoeveelheid (5 teen 12, p = 0.14) en 
gemiddelde gestasie met diagnose (21w4d teen 18w4d, p = 0.30) van tweeling 
swangerskappe of die hoeveelheid van gevalle met plasenta praevia teen 32 
weke (1 vs 1), soos bevind met sonar, nie. Die kombinasie van hierdie 
komplikasies het ook geen verskil opgelewer tussen die groepe met betrekking 
tot die hoeveelheid komplikasies (14 teen 19, p = 0.47) of die gemiddelde 
gestasie met diagnose nie (22w4d teen 19w1d, p = 0.07). 
 
Betekenisvolle verskille was gevind tussen die groepe in die mediane (1 teen 1, 
p < 0.001) en gemiddelde (0.81 teen 1.41) hoeveelheid sonars wat gedoen is per 
pasiënt. Verskille is ook gevind in die hoeveelheid sonars wat gedoen is tussen 
18 weke 0 dae en 23 weke 6 dae [330 teen 382, p = 0.003 OR (95%CI): 0.71 
(0.56 – 0.89)], die hoeveelheid sonars wat gedoen is voor 24 weke gestasie 
ouderdom [336 teen 412, p < 0.001 OR (95%CI): 0.60 (0.47 – 0.76)] en die 
hoeveelheid pasiënte wat ten minste 1 sonar ontvang het [390 teen 567, p < 
0.001 OR (95%CI) 0.18 (0.13 – 0.24)]. ‘n 74% verhoogde werkslading was 
waargeneem in Groep B. 
 
‘n Betekenisvolle verskil was gevind met die vergelyking van die hoeveelheid 
opvolg ondersoeke wat aangevra is deur die sonar departemente [105 teen 313, 
p < 0.001 OR (95%CI): 0.20 (0.15 – 0.26)]. Dit was hoofsaaklik as gevolg van die 
aansienlike verhoging in opvolg ondersoeke wat aangevra is vir fetale detail in 
Groep B [42 teen 212, p < 0.001 OR (95%CI): 0.32 (0.20 – 0.51)] en is ook 
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verantwoordelik vir die betekenisvolle verskille wat gevind is in die hoeveelheid 
opvolg ondersoeke wat aangevra is vir moontlike fetale abnormaliteite [14 teen 
11, p < 0.001 OR (95%CI): 4.22 (1.73 – 10.38)] fetale groei en Doppler [29 teen 
54, p = 0.03 OR (95%CI): 1.83 (1.05 – 3.17)] en bepaling van plasentale ligging 
teen 32 weke gestasie ouderdom [10 teen 10, p = 0.02 OR (95%CI): 3.19 (1.19 – 
8.58)]. 
 
Die twee groepe was vergelykbaar vir alle kliniese redes vir sonar verwysings 
(p = 0.60). Die verandering in verwysingsprotokol vir sekere hoë risiko pasiënte 
van TBH na Karl Bremer hospitaal vanaf die 1ste Julie 2008 het nie ‘n negatiewe 
effek gehad op die studie nie sienende dat die hoeveelheid pasiënte wat by 
Elsiesrivier vroedvrou obstetriese eenheid gekraam het, onveranderd gebly het 
(p = 0.23). Geen verskil was gevind tussen die groepe vir alle tipes kraam en 
metodes van verlossing nie.   
 
Geen verskil was gevind tussen die groepe in die hoeveelheid voortydse 
verlossings (p = 0.64) en klein vir gestasie babas nie (p = 0.42). ‘n Betekenisvolle 
verskil was gevind in die hoeveelheid post-mature geboortes [p = 0.01 OR 
(95%CI): 1.64 (1.11 – 2.41)]. Die kombinasie van hierdie komplikasies wat 
verband hou met die akkurate gestasie bepaling van swangerskappe het geen 
verskil tussen die groepe opgelewer nie (p = 0.39). Om die impak te bepaal van 
sonar na 24 weke gestasie was die hoeveelheid pasiënte wat nie ‘n sonar 
ontvang het in Groep A vergelyk met die hoeveelheid pasiënte in Groep B wat ‘n 
sonar ontvang het op en na 24 weke gestasie. Geen verskil was gevind in terme 
van voortydse verlossings (p = 0.30) en klein vir gestasie babas nie (p = 0.86). ‘n 
Betekenisvolle verskil is wel gevind in die post-mature geboorte kategorie [p = 
0.001 OR (95%CI): 2.28 (1.34 – 3.89)] en wanneer die komplikasies 
gekombineer was [p = 0.003 OR (95%CI): 1.65 (1.17 – 2.31)]. 
 
Vergelyking van die 3 swangerskaps duurte bepaling metodes (sonar, LMP 
datums en FH mates), het getoon dat sonar die geskatte datum van verlossing 
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binne 10 dae in 89.8% van gevalle akkuraat voorspel het in teenstelling met die 
66.5% voorspel deur die gebruik van die LMP datums en die 54.6% voorspel 
deur die gebruik van die FH mates. Betekenisvolle verskille was gevind tussen 
sonar en LMP datums (p < 0.001), sonar en FH mates (p < 0.001) en LMP 
datums en FH mates (p = 0.01). 
 
Die gemiddelde BMI van Groep A was betekenisvol minder (p = 0.004) as die 
gemiddelde BMI soos gevind in Groep B. Dit was bevind om van geen kliniese 
belang te wees nie. Data van die twee groepe was gekombineer om die impak 
van BMI op FH mates te bepaal. Alle pasiënte wat ‘n sonar ontvang het en ‘n 
bekende FH mate gehad het was ingesluit in die berekening. Sonar was gestel 
op nul en die verskil in weke tussen die gestasies soos bepaal deur sonar en FH 
mate was bereken. Met ‘n BMI tot en met 39.9kg/m2 is gevind dat die gestasie 
soos bepaal deur sonar en FH mates ooreengestem het binne 3 weke in 75 – 
80% van gevalle. Met ‘n BMI van 40kg/m2 en meer het die ooreenstemming 
verlaag na minder as 46% van gevalle. 
 
In Groep B het 444 pasiënte (78.2%) hul sonar afspraak binne 7 dae van 
bespreking nagekom. Van hierdie pasiënte was 23.4% se gestasie onder 18 
weke, 42.3% tussen 18 weke 0 dae en 23 weke 6 dae en 34.2% se gestasie was 
op en oor 24 weke gestasie. Dit wil sê 65.7% van pasiënte sou kwalifiseer vir ‘n 
detail sonar. In hierdie groep het die gestasie soos klinies bepaal voor sonar 
binne 2 en 3 weke ooreengestem met die gestasie soos bepaal deur sonar in 
69.6% and 82.8% van gevalle onderskeidelik. 
 
Gevolgtrekkings In hierdie populasie het slegs ongeveer 34% van pasiënte 
voordeel getrek uit die besprekings sonar protokol. Hierdie protokol kan moontlik 
beter gepas wees vir ‘n populasie met ‘n hoër  persentasie van pasiënte wat op 
en na 24 weke gestasie ouderdom bespreek. Die besprekings sonar protokol het 
die werkslading merkwaardig verhoog met min betekenisvolle voordele behalwe 
vir die verminderde hoeveelheid vermoedelike post-mature swangerskappe. 
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‘n Besprekings sonar word aanbeveel vir alle pasiënte met ‘n liggaams massa 
indeks van 40 of meer sienende dat die gestasie ouderdom soos bepaal deur die 
fundale hoogte en sonar ooreengestem het binne 3 weke of minder in minder as 
50% van gevalle. ‘n Mobiele sonar diens sal help om die bywonings tempo te 
verbeter in ‘n populasie wat in die algemeen sosiaal-ekonomies minderbevoorreg 
is. 
 
‘n Kombinasie van beide protokolle sal heel moontlik meer koste effektief wees: 
pasiënte wat bespreek met ‘n FH van minder as 26cm word geskeduleer vir ‘n 
detail sonar tussen 18 en 24 weke volgens klinies geskatte gestasie terwyl 
pasiënte wat later as 24 weke bespreek (almal of ten minste daardie met ‘n BMI 
van 40kg/m2 of meer) ‘n sonarondersoek kry so gou as moontlik na bespreking. 
Hierdie protokol sal moontlik steeds die voordele inhou van die verlaging van 
vermoedelike post-mature swangerskappe asook die aansienlike verlanging van 
die totale werkslading. Dit kan ‘n onderwerp wees vir ‘n volgende studie.  
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ND:  Not diagnosed on scan 
NS:  No scan 
OR:  Odds ratio 
PE:  Pre-eclampsia 
PH:  Pulmonary hypoplasia 
PIH:  Pregnancy induced hypertension 
PlHypo: Placental hypoperfusion 
PPROM: Preterm prelabour rupture of membranes 
SD:  Standard deviation 
SGA:  Small for gestational age 
SROM: Spontaneous rupture of membranes 
TBH:  Tygerberg hospital 
TOP:  Termination of pregnancy 
TTTS:  Twin-to-twin transfusion syndrome 
VLBW: Very low birth weight 
W:  Weeks 
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LIST OF DEFINITIONS 
 
Abruptio placenta:  Premature separation or detachment of the placenta from 
the chorion. 
Agenesis:  Congenital absence of an organ or part, usually caused by a lack of 
primordial tissue and failure of development in the embryo. 
Amniotic fluid index:  Measured after 28 weeks gestational age.  The maternal 
umbilicus is used to divide the uterus into quadrants and the deepest vertical 
pocket in each measured.  The four values are added together.  Values between 
5 and 25cm are regarded as normal. 
Body mass index (BMI):  A formula for determining obesity.  It is calculated by 
dividing a person’s weight in kilograms by the square of the person’s height in 
centimeters. 
Chorionicity:  Determining how many placentas are present in a multiple 
pregnancy.  Monochorionicity pertaining to a single placenta and dichorionic to 
two placentae. 
Deepest pool:  A means of assessing amniotic fluid volume.  Usually calculated 
prior to 28 weeks gestational age.  The deepest unobstructed pocket of amniotic 
fluid is selected and measured vertically.  Values of between 2 and 8cm are 
regarded as normal. 
Doppler:  A technique for detecting the movement of blood flow. 
Ectopic pregnancy:  An abnormal pregnancy in which the conceptus implants 
outside the uterine cavity. 
Extremely low birth weight:  Birth weight below 1000g. 
Fundal height:  The height of the fundus, measured in centimeters from the top 
of the symphysis pubis to the highest point in the midline at the top of the uterus. 
Gestational age:  Duration of pregnancy expressed in weeks.  Weeks stated 
include the days of the week up to and including the 6th day. 
Gestational diabetes mellitus:  A disorder characterised by an impaired ability 
to metabolise carbohydrates usually caused by a deficiency of insulin, occurring 
in pregnancy.  It disappears after delivery of the infant but, in a significant 
number of cases, returns years later. 
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Growth restriction:  Is diagnosed when the growth rate deviated significantly 
from an established norm.  Intra-uterine growth restriction may be implied from 
the presence of other features, such as reduced amniotic liquor, diminished fetal 
activity and abnormal Doppler waveforms. 
Hypoperfusion:  Decreased passage of fluid, like blood, through a specific 
organ or an area of the body. 
Level II hospital:  A hospital with general specialist services. 
Level III hospital:  A hospital with sub-specialist care where invasive ultrasound 
procedures are performed by maternal fetal medicine specialists. 
Low lying placenta:  Placenta inserted into the lower segment of the uterus 
within 2cm of the internal cervical os prior to 24 weeks gestational age.  The 
placenta can also cover the internal cervical os partially or completely. 
Low birth weight:  Birth weight below 2500g. 
Obstetric ultrasound protocol:  Guidelines used by doctors and nursing staff 
for the referral of obstetric patients for ultrasound. 
Placental insufficiency:  An abnormal condition of pregnancy, manifested 
clinically by a decreased rate of fetal and uterine growth.  One or more placental 
abnormalities cause dysfunction of maternal-placental or fetal-placental 
circulation sufficient to compromise fetal nutrition and oxygenation. 
Placenta praevia:  Diagnosed after 28 weeks gestational age.  Placenta 
implants in the lower segment of the uterus less than 5cm from the internal 
cervical os.  The placenta can also cover the internal cervical os partially or 
completely. 
Postmaturity:  Beyond the normal date of maturity, beyond 41 weeks or 294 
days gestational age. 
Pre-eclampsia:  An abnormal condition of pregnancy characterised by the onset 
of acute hypertension and proteinuria after the twenty-fourth week of gestation. 
Pregnancy induced hypertension:  Hypertension occurring during and caused 
by pregnancy and resolves after birth. 
Preterm labour:  Labour commencing after viability (27 weeks or 800g) and 
before 37 weeks GA. 
 xxiii 
Prophylactic:  Preventing the spread of disease. 
Pulmonary hypoplasia:  Incomplete or underdevelopment of the lungs. 
Small for gestational age (SGA):  A baby with a birth weight below the 10th 
percentile for gestational age is regarded as being small for gestational age. 
Vascular anastomoses:  Communication of blood vessels. 
Very low birth weight:  Birth weight below 1500g.
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Chapter 1 
 
INTRODUCTION 
 
Obstetric ultrasound is valuable in determining accurate gestational age (GA) 
and detecting abnormalities or complications, before it is clinically suspected. 
Ultrasound is often regarded as a luxury and not recognised as a very useful 
investigation that should form part of routine practice. The three standard 
referral protocols used are:  
 Selective scan (only if clinically indicated) 
 Routine scan (everyone booking before 24 weeks GA)  
 Booking scan for all (regardless of GA) 
Depending on the population group and availability of an ultrasound service, a 
selective scan protocol only, a routine early scan together with a selective scan 
protocol or a booking scan together with a selective scan protocol are usually 
used. In the Tygerberg region the current protocol includes a routine early 
ultrasound examination and selective referral protocol for specific clinical 
indications, regardless of whether women received a previous scan or not 
(Appendix A).1 Patients are referred for a detail scan between 18 and 23 weeks 
GA. If they are less than 18 weeks pregnant, a detailed scan is scheduled for 
approximately 21 weeks GA. Low lying placentas are followed up at 32 weeks 
GA. Patients who attend clinic for the first time beyond 23 weeks (clinical 
estimation) do not receive an ultrasound unless it is clinically indicated. Clinical 
indications for ultrasound beyond 23 weeks GA are increased fundal height (FH) 
at the second or subsequent antenatal visits, clinical suspicion of twins, FH 
measurement at the second or subsequent antenatal visits falling below the 5th 
centile for GA as determined by the use of the locally derived FH centile chart 
and suspected malpresentation at and beyond 36 weeks GA [in respect of 
patients from the local antenatal clinic at Bishop Lavis Community Health Centre 
(CHC)](Appendix B).2 The other 4 clinics, which are being serviced by the 
ultrasound department at Bishop Lavis CHC, refer patients for fetal presentation 
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directly to TBH to avoid unnecessary travelling costs should the fetus be in a 
breech position requiring referral to Tygerberg Hospital (TBH). 
 
With the use of this protocol, patients who book after 24 weeks GA do not 
receive an ultrasound unless clinically indicated. This is problematic because the 
dating of pregnancies with ultrasound at and after 24 weeks GA is not regarded 
as very accurate and the detection of fetal abnormalities is more difficult. 
However, some complications of pregnancy are detectable with ultrasound after 
24 weeks GA including congenital fetal abnormalities, multiple pregnancies and 
placenta praevia.3-5 The frequencies with which these complications occur at 
term are 2–3% (for major anomalies), 1% and 0.5–1.5% respectively. These 
complications could be life threatening to both the mother and baby/ies if the 
delivery is planned at a primary hospital, without prior knowledge of the 
condition. A booking scan with follow-up for selective clinical indications, could 
result in the earlier detection of these complications and lead to appropriate 
antenatal care and delivery management at a level 2 or 3 hospital. At the Bishop 
Lavis CHC an abnormality or complication is detected in approximately 5.4% of 
all patients scanned.6 
 
The management of obstetric patients relies heavily on the accurate 
determination of GA. The majority of patients in this region do not recall the first 
day of their last menstrual period (LMP) with great accuracy.7 This leaves health 
practitioners to determine GA from the FH measurement or ultrasound. There is 
literature evidence suggesting that ultrasound is superior to certain LMP dates in 
determining GA irrespective of the trimester in which the ultrasound examination 
was done.8 It has also been suggested that ultrasound performs better in 
determining GA than FH measurements and that FH measurement accuracy 
increases with GA.9 FH is usually used to assess fetal growth rather than GA 
and there is a lack of research determining FH accuracy in determining GA. It 
would be of value to compare the three different GA determination methods 
throughout pregnancy. The advantages would be more accurate scheduling of 
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elective caesarean sections, planned inductions of labour necessitated by 
obstetric factors, anti-retroviral therapy initiation as well as a possible reduction 
in incorrectly diagnosed postdates and preterm deliveries. 
 
A booking scan policy would mean that an ultrasound will be done as soon as 
possible after the date of first attendance with follow-up examinations for detail, 
placenta location or clinically relevant indications. Some potential advantages of 
this protocol would include more accurate dating and earlier detection of fetal 
abnormalities as well as pregnancy complications in patients booking after 24 
weeks GA. However, this may result in a drastic increase in workload and it is 
unclear whether such a protocol is warranted in an already strained health care 
environment in South Africa. 
 
Bishop Lavis CHC acts as the centre for primary level obstetric ultrasound 
examinations for five antenatal clinics (ANC) in the TBH drainage area (Belhar, 
Bellville South, Bishop Lavis, Delft and Elsiesriver). The study was conducted at 
two of these clinics, Bellville South and Elsiesriver. 
 
In order to qualify as an ultrasonographer in South Africa a 3 year national 
diploma or 3 year degree in diagnostic radiography needs to be completed prior 
to doing an additional 2 year degree in ultrasound. Ultrasonography is regarded 
as a very scarce skill in South Africa. Ultrasound has many branches or 
subdivisions and most ultrasonographers working in government hospitals 
choose a subdivision like obstetrics and gynaecology. An ultrasonographer in a 
primary hospital could screen fairly large numbers of patients in order to detect 
as many fetal abnormalities or pregnancy complications as possible and refer 
them to a level 2 or 3 hospital for appropriate management. An ultrasonographer 
also serves as an additional check-point for the detection of high risk factors 
such as increased body mass index and abnormal outcome of pervious 
pregnancies, that referring staff might have overlooked. 
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Chapter 2 
 
Tygerberg region obstetric service 
 
The Bishop Lavis CHC ultrasound service deals almost exclusively with patients 
at low obstetric risk and was started in 1996 with ultrasonography students 
scanning patients from one antenatal clinic. The student-based service was later 
expanded to a full-time service for all 5 antenatal clinics and in 2004 a qualified 
ultrasonographer was appointed. 
 
LITERATURE REVIEW 
 
Numerous studies have been conducted comparing selective and routine 
ultrasound referral protocols.10-13 It was found that there was a reduction in the 
number of suspected postdates pregnancies, inductions for postdates, 
perceived preterm labours and referrals for fetal surveillance when a routine 
ultrasound protocol was used. Routine obstetric ultrasound examinations had no 
significant impact on pregnancy outcome and were associated with a significant 
increase in the number of scans performed.12,13 
 
Major congenital fetal abnormalities are defined as those which have an adverse 
outcome on either the function or social acceptability of the individual and have 
an incidence of approximately 2 – 3%.3 These abnormalities could be life 
threatening to both mother and baby and should be managed at a tertiary 
institution as soon as possible after detection. In some cases, termination of 
pregnancy (TOP) will be offered until 24 weeks GA. However, in more serious 
cases TOP may be offered even beyond this GA in South Africa, in cases where 
there is a substantial risk of suffering from serious handicap or the abnormality is 
known not to be compatible with meaningful survival after birth.14 Some 
conditions, such as congenital diaphragmatic hernia can be treated in-utero with 
a procedure called fetal endoscopic tracheal occlusion.15 It has been previously 
reported that early detection of fetal anomalies during routine scanning, reduced 
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the perinatal mortality rate due to an increase in TOP for the anomalies.16 
However, the abnormal fetuses were merely excluded from the calculation of 
perinatal mortality and did not improve the overall pregnancy outcomes. As with 
most conditions, the earlier the abnormality is detected, the earlier management 
can be planned and treatment implemented if needed. 
 
The incidence of twin pregnancies is approximately 1% at birth.3 Fetal risks 
associated with multiple pregnancies are growth restriction, congenital 
abnormalities and intrauterine death.14 Monochorionic (MC) (monozygotic) twins 
as opposed to dichorionic (DC) twins, have a higher incidence of 
complications.14 This is mainly due to the shared placenta in MC twin 
pregnancies leading to blood volume shifts between the fetuses. The antenatal 
mortality rate for MC twins is nearly twice as high as in DC twin pregnancies and 
approximately four times as high as in singleton pregnancies.14 It is therefore 
critical to determine chorionicity correctly. Prior to 14 weeks, chorionicity 
determination is very accurate with a sensitivity of 100% and specificity of 
99%.14 However, the ultrasound signs disappear as the pregnancy progresses. 
MC twin pregnancies require much more frequent follow-up visits and closer 
surveillance to improve outcome.14 In some cases as with twin-to-twin 
transfusion syndrome (TTTS), twin reversed arterial perfusion and acute fetal 
transfusion after a single intrauterine death, treatment may involve separating 
the vascular anastomoses within the placenta with laser.14 This greatly reduces 
the risk of losing both fetuses, however timing of treatment is essential. 
Numerous authors have found that the earlier detection of multiple pregnancies 
is not associated with an improved outcome.10,11,16,17 However, the earlier a twin 
pregnancy is identified, the better chance of correctly determining chorionicity 
and subsequently planning the management of the pregnancy or treatment if 
required.14 Even though MC twins carry a higher complication rate than DC twin 
pregnancies, more than three quarters of twin pregnancies are DC.18 When 
compared with singleton pregnancies, DC twin pregnancies demonstrate an 
increased risk for preterm birth, intrauterine growth restriction (IUGR) and 
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perinatal mortality. The presence of a twin pregnancy will also lead to an 
incorrect GA determination by FH if an ultrasound is not performed. 
 
Placenta praevia occurs in approximately 0.5 – 1.5% of pregnancies.4 The 
placenta is inserted partially or completely into the lower segment with varying 
degrees of obstruction of the internal cervical os. The aetiology is unknown, 
however age, parity and previous caesarean delivery have been identified as 
possible factors of association.14 Other risk factors include cigarette smoking, 
drug abuse, previous abortion and previous placenta praevia.14 The mother runs 
the risk of severe haemorrhage and even death if left untreated. Fetal risks 
include preterm birth, fetal growth restriction in up to 16% of cases, an almost 
double increased incidence of serious fetal malformations and umbilical cord 
complications such as cord prolapse or compression.14 The overall perinatal 
mortality rate due to placenta praevia causing preterm birth has lowered from 
approximately 126 per 1000 nearly 23 years ago to 42 to 81 per 1000.14 This is 
mostly due to conservative management and improved neonatal care. Based on 
the literature approximately 28% of women have a low lying placenta at the time 
of their detail scan.14 This percentage lowers to 18% at 24 weeks and to 3% at 
term. Most centres, including TBH, rescan patients who have a low lying 
placenta at 20 to 23 weeks at 32 weeks.14 Placenta localisation is not currently 
checked in patients who book after 24 weeks GA. With a booking scan protocol 
more cases of placenta praevia could be detected before complications arise, 
the pregnancy can be managed expectantly with the aim to prolong the 
pregnancy and antenatal steroids can be administered to enhance fetal lung 
maturity and thereby reducing the antenatal mortality further. 
 
Polyhydramnios or hydramnios is defined as an ultrasonographically measured 
deepest pool (DP) of 8cm or greater, an amniotic fluid index (AFI) of 25cm or 
greater or above the 95th centile for GA.14,19 This condition affects approximately 
0.2% of pregnancies with various known causes.14,19 Of these causes, maternal 
diabetes mellitus, inability of the fetus to swallow, various fetal anomalies, TTTS, 
fetal anaemia and congenital infections are the most significant. The most 
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frequent maternal complications encountered are due to uterine distention.14,19 
There is also an increased incidence of caesarean section due to placental 
abruption and unstable fetal lie.14 Antenatal mortality rates associated with 
polyhydramnios are approximately 5%.14 This is mainly due to preterm prelabour 
rupture of membranes (PPROM) and subsequent preterm delivery as well as the 
presence of fetal malformations. The aim of general management of patients 
with polyhydramnios is to alleviate maternal symptoms and to prolong the 
pregnancy as far as possible.14 Treatment is usually only indicated in those 
cases with moderate to severe polyhydramnios. Treatment will usually be 
directed at the underlying cause, however therapeutic amniocentesis may be 
indicated.14 This procedure carries various risks, however it has been proven to 
prolong pregnancies and improve survival. In cases where FH is used to 
determine GA, polyhydramnios will only be suspected in those cases where the 
FH increases rapidly. The presence of polyhydramnios will also lead to an 
incorrect GA determination if an ultrasound is not performed. 
 
Oligohydramnios is defined as a DP of 2cm or less, an AFI of 5cm or less or 
below the 5th percentile for GA.14,19 The most common causes of 
oligohydramnios are PPROM, IUGR, chronic placental insufficiency, 
postmaturity and fetal anomalies.14,19 Oligohydramnios is associated with an 
increased risk of caesarean section for fetal distress due to IUGR, fetal 
anomalies or umbilical cord compression.14 Prematurity with subsequent low 
birth weight is a risk factor as well as pulmonary hypoplasia (PH) and skeletal 
deformities due to prolonged oligohydramnios.14,19 The aims of managing 
patients with oligohydramnios will be to establish the aetiology and if the fetus is 
viable to monitor the fetal condition thus reducing perinatal mortality.14 The 
presence of oligohydramnios will complicate GA determination if an ultrasound 
is not performed. The condition will only be suspected at the follow-up antenatal 
clinic visit if poor increase in FH is present and the 10th centile is crossed on the 
FH centile chart (Appendix B).2 Timing of treatment in this condition is critical. 
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Subsequent to the detection of abnormal findings on ultrasound the patients 
need to be referred to the appropriate level of care for further management. The 
frequency of antenatal visits will be higher, compared to the low frequency (4 – 8 
week intervals) of visits appropriate for low risk patients. 
  
In combination, the above mentioned conditions constitute approximately 4 – 5% 
of pregnancies indicating that 5 out of every 100 patients who book after 24 
weeks GA could have one of these conditions. With the current scanning 
protocol patients booking after 24 weeks do not routinely receive an ultrasound. 
Therefore, unless the condition worsens or the patient presents with symptoms 
like bleeding or with excessive or very poor growth in FH, the medical staff will 
never be aware of the condition being present. 
 
Hypothesis: 
Providing a booking scan to patients booking at or after 24 weeks GA, far more 
cases with pregnancy complications will be detected, leading to improved 
antenatal care and possibly pregnancy outcome. 
 
Accurate dating of pregnancies is essential to make clinical decisions and to 
evaluate the fetus for growth disturbances during the pregnancy. Most centres, 
including TBH and the primary care antenatal clinics within the Tygerberg 
region, use the following method for dating at the first antenatal clinic visit. 
 When the first day of the last LMP is sure and the ultrasound findings are 
in keeping with the GA according to the LMP (within 7 days in the first 
trimester, 10 – 14 days between 15 and 24 weeks and 21 days from 24 
weeks onwards) the GA according to the LMP is used as the correct 
GA.14 
 If the GA according to ultrasound in the first and second trimesters (up to 
24 weeks) is not in keeping with the GA according to the LMP or the LMP 
dates are unsure, the average GA according to the ultrasound is used.20 
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 In cases where the LMP dates are sure and where the GA is more than 
24 weeks and the GA by FH correlates within equal or less than 4 weeks, 
the GA according to the LMP is used as the correct GA.20 
 If the LMP dates are unsure in the third trimester or are not in keeping 
with the GA according to the FH, the GA according to the FH will be 
regarded as the correct GA.20 FH can be used to determine GA from a 
measurement of 18cm which corresponds to a gestation of approximately 
20 weeks. The FH in centimetres is plotted on the 50th centile on the FH 
centile chart compiled on the same patient population as the index study.2 
According to the ultrasound protocol followed in the Tygerberg Region 
Obstetric service and approved by the department of Obstetrics and 
Gynaecology at TBH, if the LMP is uncertain and the FH measures 23cm 
or more a routine scan will not be done (Appendix A).1 On the FH centile 
chart 23cm corresponds to 24 weeks if plotted on the 50th centile. This 
protocol was followed during the index study for the routine ultrasound 
group. 
 
Accurate dating of pregnancies with ultrasound starts at 7 weeks GA. Patients 
who are less than 7 weeks pregnant are provided with a follow-up appointment 
for accurate dating at approximately 12 weeks GA. GA determination by 
ultrasound between 7 weeks 0 days and 11 weeks 6 days is achieved by 
measuring the crown-rump length (CRL), between 12 weeks 0 days and 13 
weeks 6 days by measuring the CRL, biparietal diameter (BPD), head 
circumference (HC) and abdominal circumference (AC).21-23 Beyond 13 weeks 6 
days GA determination by ultrasound is done by measuring BPD, HC, AC and 
femur length (FL).22-24 The ultrasound machine determines the average of the 
GA according to the different individual measurements and this is then used as 
the GA, on condition that the measurements are concordant and the fetus not 
anomalous. Determining GA with ultrasound at and after 24 weeks GA is not 
regarded as being very accurate and the clinical information (FH measurement 
and or LMP dates) on GA estimation should be taken into consideration. 
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The CRL is measured from the head of the fetus to its buttocks with the fetus in 
a neutral position, excluding the limbs and yolk sac.21 The fetal head is 
measured on a transverse plane of the head at the level where the midline is 
continuous and interrupted by the cavum septum pellucidum in the anterior 
third.22 The BPD is measured from the outer edge of the parietal bone nearer 
the transducer to the inner edge of the opposite parietal bone (outer-inner). The 
HC is measured on the BPD plane as the perimeter around the outer edge of 
the skull excluding the skin. The AC is measured as the outer perimeter of the 
fetal abdomen on a transverse plane at the level of the stomach and the intra-
hepatic portion of the umbilical vein situated in the anterior third of the abdomen, 
including the skin.23 The spine is identified posteriorly with the descending aorta 
located anterior to this. Both the HC and AC are measured by the use of an 
expanding ellipse. The FL is measured on an image demonstrating a femoral 
diaphysis in its entirety in a plane as close as possible to right angles to the 
ultrasound beam.24 The femoral head and distal epiphysis are not included in 
the measurement and a straight measurement is made, disregarding the 
curvature of the femur. 
 
Other investigators working in Africa found that patients do not recall the date of 
their LMP with great accuracy and routine antenatal ultrasound is not widely 
available.7,25 In our setting, a routine ultrasound protocol is in use and patients 
who book at or after 24 weeks 0 days GA will only receive a scan if clinically 
indicated. Therefore, dating pregnancies, especially in the third trimester relies 
heavily on an accurate FH measurement. It has been suggested previously that 
ultrasound performs better in determining the GA throughout pregnancy when 
compared to certain LMP dates and predicts GA more accurately than FH 
measurements.8,9,26 A study conducted in the Central African Republic in 1995 
revealed that 45% and 63% of patients delivered within 2 and 3 weeks 
respectively of the estimated due date (EDD) as predicted by the FH.25 
However, there has been very limited research done on the accuracy of FH 
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measurements in GA determination and the effect of increased body mass index 
(BMI) on FH measurements. 
 
Birth weight (BW) is classified as low (<2500g), very low (<1500g) or extremely 
low (<1000g).14 In the TBH region, 23.9% of babies born in 2008 had low BW.27 
This percentage includes live as well as still births. Of live births, 21.4% were 
classified as having low BW.27 Major causes of low BW include prematurity and 
growth restriction [or small-for-gestational age (SGA)]. Preterm labour refers to 
labour that commences after viability (in our setting 27weeks or 800g if GA is 
unknown) and before 37 weeks GA. The incidence of preterm labour in 
developed countries is around 5 to 10%.14 It is often caused by and associated 
with intrauterine infections, placental abruption or placenta praevia and cervical 
incompetence.14 One of the biggest risk factors for the fetus is the risk of 
prematurity which could lead to respiratory distress syndrome, intracranial 
haemorrhage or pulmonary haemorrhage.14 The percentage of patients with 
suspected preterm labour increases when GA is not accurately determined. This 
could lead to an increased number of deliveries being incorrectly considered to 
be preterm and more patients being referred unnecessarily to higher levels of 
care.13 When a baby is born without prior knowledge of the GA at which birth 
took place, the BW together with the Ballard score is used to determine GA.28 
This method shows a 92% agreement with antenatal ultrasound for all postnatal 
gestational weeks (equal or greater than 28 weeks) up to 96 hours after birth. A 
centile chart for birth weights compiled on the same patient population as the 
index study is used for this purpose.29 SGA babies have lower birth weights 
however they follow their own growth curve and may just be constitutionally 
small. SGA babies have a higher risk of perinatal compromise and of developing 
adult disease. A larger percentage of babies will be labelled SGA (or large for 
GA) if the GA is determined incorrectly and an incorrect diagnosis will result in 
undue anxiety.30  
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Postdates pregnancy is defined by The International Federation of 
Gynaecologists and Obstetricians as a pregnancy that continues for more than 
294 days or 42 weeks after the last menstrual period.14,31 This definition was 
used for the purposes of this study and labour is traditionally induced when 42 
weeks is reached because the risk of stillbirth from 42 weeks onward is 1 in 
1000 pregnancies and at 43 weeks 1 in 500. There is also an increased risk of 
birth asphyxia and trauma.14 The most prominent maternal risk of induction of 
labour for postdates pregnancy is an increased risk of caesarean section.14 The 
benefits of providing a booking scan for every patient regardless of GA in order 
to reduce the number of false preterm and postdates pregnancies by a better 
estimation of GA needs to be investigated to confirm the results found by other 
authors.10-13 Postdates pregnancies are routinely referred from primary level of 
care to the next level of care for possible induction. Because a large proportion 
of patients in this area tend to book late, do not receive an ultrasound and do not 
recall their LMP dates with great accuracy, a conservative induction policy is 
used.  If a postdates pregnancy is suspected, an AFI scan and cardiotocogram 
(CTG) are performed. The patient will be considered for induction if the AFI is 
less than 5cm or the CTG gives  a poor result.32 The fetal evaluation clinic at 
TBH examined approximately 600 patients for suspected postdates pregnancies 
in 2008.33 A booking scan for all patients may significantly reduce the number of 
unnecessary referrals to the fetal evaluation clinic for suspected postdates 
pregnancy. 
 
Accurate fetal size determination could be problematic in an overweight or 
obese patient. According to the World Health Organization normal weight is 
defined as a BMI of 20 – 25 kg/m2, overweight as more than 25 kg/m2 and a BMI 
greater than 30 kg/m2 is known as obesity.34 Obesity (outside of pregnancy) is 
divided into 3 categories or grades: I = BMI 30 – 34.9 kg/m2, II = BMI 35 – 39.9 
kg/m2, III = BMI equal or more than 40 kg/m2. Obesity in pregnancy holds a 
number of risks for both the mother as well as the fetus including pregnancy 
induced hypertension and gestational diabetes.14,35 Due to the increased risk of 
complications during pregnancy as well as the birth, patients with a BMI of 40 
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and greater are referred as level II patients to TBH for high risk management. An 
area of interest was the influence of BMI on the accuracy of FH measurements 
in determining GA after 18 weeks. 
 
Approximately 16.1% of pregnant women in the Western Cape are infected with 
the Human Immunodeficiency Virus (HIV).36 Preventing perinatal transmission of 
the virus from mother to child is a high priority within this health service. 
Transmission will occur in 20 – 30% of women who do not receive treatment and 
do not breastfeed. Approximately half of transmissions in untreated women 
occur during delivery and 20% during the third trimester of pregnancy.37 A HIV-
infected woman who breastfeeds has a further 30% risk of transmitting the virus 
to her child. With treatment, the perinatal transmission rates have decreased to 
1 – 2% in developed countries.14,38 In the Cape Town Metropolitan area the 
transmission rate was approximately 4.8% in 2008.39 According to the then 
current antenatal retroviral treatment protocol, HIV-infected patients with CD4 
counts of 250 cells per cubic millilitre or more started their prophylactic treatment 
at 28 weeks GA or at booking if it took place after 28 weeks GA.40 Patients with 
lower CD4 counts starts highly active anti-retroviral treatment as soon as 
feasible. Again, dating after 24 weeks GA will depend on an accurate FH 
measurement. A more accurate dating method, ultrasound in the third trimester, 
could contribute to commencing anti-retroviral treatment timeously. 
 
Additional information regarding the correct obstetric ultrasound policy to 
improve maternal care and perinatal outcome is required. A comprehensive 
study was therefore planned to investigate two different ultrasound screening 
protocols. 
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Chapter 3 
 
AIMS OF THE STUDY 
 
The primary aim of the study was to compare 2 ultrasound referral protocols 
regarding the number of clinically relevant abnormalities (congenital fetal 
abnormalities, multiple pregnancies, placenta praevia, suspected abnormal fetal 
growth, pregnancy loss and abnormal liquor) detected prior to delivery and their 
GA at diagnosis: 
 The current protocol of routine early ultrasound scans (18 – 23 weeks) 
and scans for selective clinical indications (Control Group / Group A) 
 The new protocol of booking scan for all, regardless of GA, and follow-up 
for selective clinical indications (Study Group / Group B). 
 
The following were the secondary aims of the study: 
1. Comparing the number of patients receiving an ultrasound and the total 
number of scans performed in each group, including all follow-up scans. 
The above information can be used to determine the workforce and 
resources that would be required to implement the different ultrasound 
referral protocols. 
2. Comparing the number of patients receiving an ultrasound between 18 
and 23 weeks GA since this is regarded as the most appropriate time 
interval for a detailed scan. The detail scan is one of the most important 
scans to be performed for obstetric management and the higher the rate 
of scanning during this period, the better the expected detection rate for 
fetal abnormalities and complications. 
3. Comparing the percentages of (presumed) postdates or preterm 
pregnancies and SGA babies between both groups, both in cases who 
received an early ultrasound (less than 24 weeks GA) and cases in 
Group A that did not have an ultrasound examination (because the GA 
was estimated to be equal or more than 24 week 0 days) or cases that 
had a GA of 24 weeks 0 days or more when they had their first ultrasound 
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examination in Group B. This information will indicate whether late 
ultrasound scanning contributes to more accurate GA determination. 
These outcomes will be noted in the study population if: 
 A patient delivered beyond 41+6 weeks GA or before 37 weeks 
 A baby was diagnosed to be SGA according to the GA used in the 
management and the local BW reference range. 
4. Determining which of the three dating methods (LMP, FH measurement 
or ultrasound) estimates the date of delivery most accurately. A 
comparison of GA at delivery was made in patients with a spontaneous 
onset of labour and normal BW (defined as falling within the 10th and 90th 
centiles for GA according to the locally derived BW centile chart29) who 
had sure LMP dates and a known FH measurement and who received an 
ultrasound scan. 
5. Determining the influence of the BMI on the accuracy of GA 
determination by means of a FH measurement. The BMI of those patients 
who received an ultrasound was categorised. FH must have been known 
at the time of the ultrasound examination. Ultrasound GA estimation was 
used as the reference. 
6. Obtaining more accurate data on booking tendencies by calculating the 
GA at booking, confirmed by ultrasound. 
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Chapter 4 
 
METHODOLOGY 
 
An analytical audit was done on a low-risk population attending 2 public sector 
antenatal care facilities in the Cape Town Eastern metropolitan area. Firstly the 
audit was done with the current referral protocol in place consisting of a routine 
early ultrasound with selective scans for specific clinical indications. Following 
this audit the ultrasound protocol was changed to a booking scan for all with 
selective scans for specific clinical indications and another audit was done. The 
study followed a participatory action research model. 
 
The study was conducted at the Elsiesriver CHC and Bellville South CHC for 
recruitment and Bishop Lavis CHC, Karl Bremer Hospital (KBH) and TBH for the 
ultrasounds. Recruitment commenced in October 2007. At that time TBH was 
the only referral hospital for the two antenatal clinics in question. In July of 2008, 
the referral system for certain high risk cases was changed and patients were 
also referred to KBH for antenatal care and delivery. 
 
The study population consisted of all low-risk patients booking at Elsiesriver 
CHC and Bellville South CHC for antenatal care. Patients were excluded if they 
had any maternal medical condition or historical risk factor that would categorise 
them into a high risk group that requires referral to the high risk clinics at KBH 
and TBH, or ultrasound unit at TBH. Patients who received an ultrasound prior 
to booking were also excluded. 
 
Waiver of informed consent was granted by the Committee of Human Research 
of the University of Stellenbosch since the proposed research tested accepted 
routine referral policies and posed no more than minimal risk or cost to the 
subjects. 
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The first time period to collect data for Group A commenced on 8 October 2007 
and continued until 28 January 2008. Recruitment was interrupted between 10 
December 2007 and 4 January 2008 to compensate for the decreased booking 
rate during the festive season. Data was collected by the researcher on a daily 
basis on all patients who came for booking on the day. Patients were referred for 
ultrasound on the basis of the current ultrasound referral protocol by the 
antenatal nursing staff. Only patients who were thought to be less than 24 
weeks pregnant were referred for a detailed ultrasound between 18 and 24 
weeks GA. The first time period continued until 750 patients, who met the 
inclusion criteria, booked. 
 
The second time period to collect data for Group B commenced on 4 February 
2008 and continued until 28 April 2008. The ultrasound referral protocol was 
changed to the booking scan policy, whereby all patients were referred for an 
ultrasound regardless of their GA. This time period also continued until 750 
consecutive low-risk patients booked. An ultrasound was arranged for them 
within 7 days of booking. This allowed the patients to make arrangements at 
home and at work in order to attend the ultrasound department. 
 
Ultrasound examinations were performed at Bishop Lavis CHC on a Toshiba 
Justvision 400, at KBH on a Toshiba Eccocee (Toshiba, Japan) and on an Aloka 
3500 (Aloka, Mitaki-Shi, Tokyo) and a Siemens Antares Sonoline (Siemens, 
Germany) at TBH. All machines used 3.5 MHz curvilinear probes. The Toshiba 
Justvision 400 does not have Doppler capabilities. 
 
Scans for clinical indications were performed on patients from both groups, 
regardless of GA and whether they received a previous scan or not. Patients 
from both groups, who were found to be less than 18 weeks pregnant, had a low 
lying placenta or any condition that requires follow-up, were given a follow-up 
date for a detailed scan at 18 to 23 weeks GA or placentography at 32 weeks 
GA. The referring nursing staff used the Perinatal Education Program criteria to 
 41 
calculate GA prior to ultrasound (Appendix C).20 GA was not altered if the GA 
according to ultrasound corresponded with the LMP determined GA within the 
variation calculated by the ultrasound machine prior to 16 weeks GA, within 2 
weeks between 16 and 23 weeks 6 days GA and within 3 weeks at and after 24 
weeks GA. 
 
The following clinically relevant information was noted during the ultrasound 
examinations. Lie of the fetus, position and distance of the placenta from the 
internal cervical os, number of fetuses, amniotic fluid volume and presence or 
absence of fetal abnormalities. A placenta was regarded as being low lying if its 
cervical margin was within 2cm from the internal cervical os prior to 24 weeks 
GA. Thereafter, a distance of less than 5cm was required for a placenta to be 
regarded as being low-lying or placenta praevia after 28 weeks GA. Low-lying 
placentas were followed up at 32 weeks. If it was praevia at that time the patient 
was referred to the high risk clinic at TBH. 
 
The following was regarded as ultrasound evidence of fetal growth 
abnormalities: 
 Growth restriction – reduced liquor, head measurements normal with AC 
under the 5th centile for GA (asymmetric growth), HC/AC ratio above the 
95th centile for GA and estimated fetal weight (EFW) below the 10th 
centile for GA. 
 Macrosomia – late in the third trimester, AC above the 95th percentile for 
GA, liquor volume normal or increased. 
 
Ultrasound evidence of amniotic fluid volume abnormalities included: 
 Polyhydramnios – deepest pool measuring more than 8cm or AFI more 
than 25cm. 
 Oligohydramnios – deepest pool measuring less than 2cm or AFI less 
than 5cm. 
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When fetal abnormalities or complications were detected, the patient was 
referred to the ultrasound unit at TBH. Abnormal ultrasound findings do not 
always have an impact on antenatal management or pregnancy outcome. An 
example of this is a finding of isolated club feet. Termination of pregnancy will 
not be offered in such a case and obstetric management will remain the same 
as if the abnormality was not present. 
 
The FH centile chart of all recruited patients was checked within 2 weeks of 
booking to confirm inclusion and to determine clinical GA. Ultrasound results 
were gathered by the researcher and the personnel at the TBH and KBH 
ultrasound units. The Astraia database at the TBH ultrasound unit was checked 
for GA at time of first ultrasound, multiple pregnancies, confirmation of 
abnormalities or complications detected at Bishop Lavis CHC and follow-up 
results. Uncomplicated deliveries took place at Elsiesriver Midwife Obstetric Unit 
(MOU) and both patients from the Elsiesriver and Bellville South antenatal 
clinics delivered there. The birth registries at Elsiesriver MOU, TBH and KBH 
were checked for date of delivery, spontaneous onset of labour and mode of 
delivery, BW and 5 minute Apgar score of the baby. Complications during 
delivery were also noted. Medical records were reviewed in cases of neonatal or 
intensive care unit admission, delivery prior to 37 weeks GA, BW less than 2500 
grams, intra-uterine death (IUD), neonatal death, any antenatal admission, 
presence of abnormalities and poor perinatal outcome. The last patient delivered 
in January 2009. 
 
The required sample size was calculated with the α-value at 0.05 and the β-
value at 20% (power 80%), assuming a 10% complication detection rate in the 
group prior to the change in policy and a 15% complication detection rate 
thereafter. Seven hundred and fifty patients (total 1500) were required for each 
group. These calculations assumed a 40% scanning rate prior to change in 
policy and a 90% scanning rate thereafter. The SPSS version 16 statistical 
package for social science was used to analyze the data. Continuous variables 
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with a normal distribution were analyzed with Student’s t-test. In case of a 
skewed distribution, medians were compared with the Mann Whitney U-test. 
Discrete data was analyzed using Chi-square and small numbers using Fisher’s 
exact test. Chi-square and Fisher’s exact tests were performed using Epi Info 
version 3.5.1, August 13, 2008. A probability (p) level of less than 0.05 was 
regarded as significant. 
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Chapter 5 
 
RESULTS 
 
A total of 1500 low risk patients who booked consecutively were recruited in the 
study, with groups A and B each comprising of 750 patients. Outcome of 
pregnancy was known in 631 cases in Group A and in 629 cases in Group B. 
 
Table 1 contains a summary of the population characteristics and pregnancy 
outcome. Patients were confirmed to be not pregnant with a strip pregnancy test 
(U – Test pregnancy®) provided by Humor Diagnostica. Miscarriages consisted 
of all cases where pregnancy failed prior to viability (27 weeks / 800g), including 
one ectopic pregnancy in Group B, early negative fetal heart action as 
diagnosed with ultrasound and patients who were confirmed not to be pregnant 
anymore after a previous positive pregnancy test followed by vaginal bleeding. 
Some of these patients did not have a scan. The 3 TOP cases in Group A were 
all performed for fetal abnormalities. The 1 TOP in Group B was on the patient’s 
request. IUD was confirmed with ultrasound in all but one case in Group B. 
Cases of IUD was excluded from the calculations for mean BW and Apgar 
score. The maternal death in Group A occurred at 26 weeks 3 days GA and is 
not included in the miscarriage sub-group.  
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Table 1 Population characteristics and pregnancy outcome in groups A 
and B. Values are number (%), mean (standard deviation) or 
median (range) as appropriate 
 Group A Group B p OR (95% CI) 
Pregnancies with 
known outcome* 
631 (84.1) 629 (83.9) 0.94  
Infants with known 
outcome 
623 
 
616 
 
  
Age (years) ^ 25.74 (5.49) 25.32 (5.49) 0.18  
Gravidity^ 2.03 (1 – 6) 1.94 (1 – 6) 0.17  
Parity^ 0.9 (0 – 5) 0.83 (0 – 5) 0.23  
BMI^ 26.59 (6.27) 25.91 (5.71) 0.004  
Live born infantsҰ 616 (98.9) 610 (99.0) 0.98  
Mean BW# 3055.3(558.5) 2996.1(582.3) 0.07  
LBW Ұ 84 (13.5) 98 (15.9) 0.29  
VLBW Ұ  2 (0.3) 14 (2.3) 0.006 0.14(0.02–0.65) 
ELBW Ұ 1 (0.2) 0 (0) 1.00  
LBW excl. Twins,IUDҰ 77/618 (12.5) 79/612 (13.0) 0.77  
Women delivered^ 618 (97.9) 605 (96.2)   
Mean GA at delivery ф 39.1 (2.68) 38.9 (2.47) 0.10  
    < 37 weeks ф 96 (15.5) 101 (16.7) 0.64  
    ≥ 42 weeks ф 81 (13.1) 51 (8.4) 0.01 1.64(1.11–2.41) 
5min Apgar# 10 (1 – 10)  10 (3 – 10) 0.001  
5min Apgar below 7# 11(1.8)  4(0.7) 0.12  
Twin pregnancy 5 12 0.14  
Miscarriages  6 14 0.11  
Not pregnant 3 9 0.15  
TOP 3 1 0.62  
IUD 7 6 1.00  
ENND$ 1 1 1.00  
Maternal death$ 1 1 1.00  
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BMI: body mass index; BW: birth weight in grams; LBW: low BW < 2500 grams; 
VLBW: very LBW < 1500 grams; ELBW: extremely LBW < 1000 grams; TOP: 
termination of pregnancy; IUD: intra-uterine death; ENND: early neonatal death; 
*: % of patients recruited; ^: % of patients with known pregnancy outcome; Ұ: % 
of infants with known outcome; #: live born infants only; ф: % of women delivered; 
OR: odds ratio; CI: confidence interval; $: cases of ENND and maternal death 
are discussed on pages 35 and 36 
 
Table 2 contains a summary of the ultrasound findings at both locations, Bishop 
Lavis CHC and TBH. The ultrasound findings refer to the complications or fetal 
abnormalities detected. The early pregnancy loss rate and the number of non-
pregnant cases for Group A were probably much higher. Patients in Group A 
received an appointment for ultrasound between 18 and 23 weeks GA at which 
time the early pregnancy losses and non-pregnant cases would have been 
recognised already and lost to follow-up as patients tend not to report a 
pregnancy loss or absence of pregnancy to the antenatal clinic. If the early 
pregnancy losses and non-pregnant cases were disregarded in both groups the 
difference of complications and abnormalities detected antenatally between the 
two groups were found not to be significant (p = 0.57). In Group A 1 case of 
talipes and another with fibroids were overlooked at Bishop Lavis CHC and later 
diagnosed at TBH. One case in Group A with suspected fetal heart defect 
diagnosed at TBH was not confirmed with post-natal ultrasound. There were 5 
cases in group B where complications or abnormalities were suspected at 
Bishop Lavis CHC and then not confirmed at TBH. 
 
 47 
Table 2 The complications and abnormalities detected with ultrasound in 
both groups 
 Group A 
BL / Total 
Group B  
BL / Total 
p OR (95%CI) 
Total (%)* 34/44 (7.0)  59/68 (10.8) 0.02 0.62 (0.41 – 0.94) 
Not pregnant^ 1/1 (2.3) 9/9 (13.2) 0.09  
Early pregnancy loss^ 1/1 (2.3) 11/11 (16.2) 0.03 0.12 (0.01 – 0.96) 
Gynaecological findings^ 8/9 (20.5) 5/5 (7.4) 0.08  
Increased liquor^ 3/4 (9.1) 3/7 (10.3) 1.00  
Decreased liquor^ 0/0 0/2 (2.9) 0.52  
Abnormal fetal findings^ 7/9 (20.5) 6/8 (11.8) 0.33  
Twins^ 4/5 (11.4) 12/12 (17.6) 0.53  
Malpresentation > 36 
weeks^ 
0/1(2.3) 0/0 0.40  
Early low placenta^ 9/10 (22.7) 10/10 (14.7) 0.41  
Placenta praevia > 32 
weeks^ 
0/1 (2.3) 1/1 (1.5) 1.00  
Suspected growth 
restriction^ 
1/3 (6.8) 2/3 (4.4) 0.68  
BL / Total: number of cases detected at Bishop Lavis CHC / Total number of 
cases; OR: odds ratio; CI: confidence interval; *: % of pregnancies with known 
outcome; ^: % of complications and abnormalities detected 
 
Table 3 contains a summary of the abnormalities or complications at birth in 
both groups. The performance of an ultrasound examination would not have 
made a difference in antenatal management in the cases with acute neonatal 
morbidity, acute maternal post-partum morbidity, birth before arrival, intra-
uterine death, spontaneous fetal loss or maternal death. In the one case of fetal 
loss, a negative fetal heart action was noted at 21 weeks GA without the 
knowledge or suspicion of the mother or the nursing staff. In the one case of 
early neonatal death (ENND) in Group A ultrasound would not have altered the 
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antenatal management as the baby died due to sepsis. In the one case of ENND 
in Group B ultrasound could have had an impact on antenatal management as 
the baby died due to a renal abnormality. One case of talipes in Group A was 
overlooked at Bishop Lavis CHC.  In Group B one case of talipes and one case 
of atrial-ventricular septal defect was overlooked at Bishop Lavis CHC. None of 
the early (before 20 weeks GA) miscarriages or the termination of pregnancy on 
the patient’s request were included.  
 
Table 3 Abnormalities or complications at birth in groups A and B 
Abnormalities or  
Complications 
Group A 
No scan / Total  
Group B 
No scan / Total 
p 
Number* 29/77(12.2) 4/64 (10.2) 0.29 
Acute neonatal morbidity^ 8/25(32.5) 0/24(37.5) 1.00 
Acute maternal post-partum 
morbidity^ 
3/6(7.8) 0/4(6.3) 0.75 
Breech delivery^ 2/2(2.6) 0/0 0.50 
Birth before arrival^ 8/16(20.8) 2/12(18.8) 0.57 
Early neonatal death^ 1/1(1.3) 1/1(1.6) 1.00 
Intrauterine death^ 4/7(9.1) 1/6(9.4) 1.00 
Twins^ 0/5(6.5) 0/11(17.2) 0.21 
Miscarriage after 20 weeks^  2/3(3.9) 0/0 0.25 
Fetal abnormalities^ 1/8(10.4) 0/5(7.8) 0.58 
TOP for fetal abnormalities^ 0/3(3.9) 0/0 0.25 
Maternal death^ 0/1(1.3) 0/1(1.6) 1.00 
No scan / Total: cases that did not receive an ultrasound / total number of 
abnormalities or complications; OR: odds ratio; CI: confidence interval; *: % of 
pregnancies with known outcome; ^: % of abnormalities or complications at 
birth; TOP: termination of pregnancy 
 
Flow diagrams 1 and 2 and table 4 aids in demonstrating the impact ultrasound 
had on the birth complications in both groups. 
 49 
Flow diagram 1 Impact of ultrasound on the birth complications in Group A  
 
*: % of patients with known outcome; #: % of birth complications; ^: % of patients 
with birth complications that did not receive an ultrasound; $ : % of patients with 
birth complications that received an ultrasound  
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 50 
Flow diagram 2 Impact of ultrasound on birth complications in Group B 
*: % of patients with known outcome; #: % of birth complications; ^: % of patients 
with birth complications that did not receive an ultrasound; $ : % of patients with 
birth complications that received an ultrasound 
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Table 4 Birth complications and the impact of ultrasound on the outcome 
 Group A  Group B  p  OR (95% CI) 
Birth complications* 77 (12.2)  64 (10.2)  0.29  
No scan done# 29 (37.7)  4 (6.5)  <0.001 9.06 (2.77–32.8) 
 No difference^ 27 (93.1)
  3 (75.0)  0.33  
 Difference^ 2 (6.9)
  1 (25.0)  0.33  
      Scan done# 48 (62.3)  60 (93.7)  <0.001 0.11 (0.03–0.36) 
 No difference$ 30 (62.5)
  44 (73.3)  0.32  
 Difference$ 17 (35.4)
  14 (23.3)  0.24  
Abnormalities missed$ 1 (2.1)  2 (3.3)  1.00  
*: % of patients with known outcome; #: % of birth complications; ^: % of patients 
with birth complications that did not receive an ultrasound; $: % of patients with 
birth complications that received an ultrasound 
 
Table 5 contains a summary of the congenital fetal abnormalities in groups A 
and B. The difference in prenatal detection (7/8 vs. 3/6) was not significant 
(p = 0.1). 
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Table 5 Congenital fetal abnormalities and the gestational age (GA) at 
diagnosis for groups A and B 
Group A GA Group B GA 
Bilateral talipes ND Unilateral talipes ND 
Bilateral talipes 19w0d Trisomy 21 with AVSD ND 
Amnion band syndrome 20w2d Renal abnormality NS 
Diaphragmatic hernia 20w6d Trisomy 21 with AVSD 23w0d 
Spina bifida 22w0d Unilateral renal agenesis 23w1d 
Bilateral talipes 24w3d Cleft lip and palate 25w3d 
Craniofacial abnormalities 
incl. cleft lip and palate, eye 
abnormality, brain dysplasia, 
bilateral talipes 
25w6d   
Unilateral talipes 28w6d   
w: weeks; d: days; ND: Not diagnosed on scan; NS: No scan; AVSD: atrial-
ventricular septal defect  
 
Table 6 consists of a comparison between the two groups with regard to the 
percentages and mean GA at diagnosis of congenital fetal abnormalities, twin 
pregnancies and placenta praevia at 32 weeks GA. These complications were 
also evaluated together. 
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Table 6 Comparison of mean gestational age (GA) at diagnosis of 
congenital fetal abnormalities, twin pregnancies and placenta 
praevia in groups A and B 
 Group A Group B p - value 
Fetal abnormalities* 8 (1.3) 6 (1.0) 0.79 
Mean GA at diagnosis 23w0d 23w6d  
Range 19w0d–28w6d 23w0d–25w3d  
Diagnosed < 24 weeks 4 1 0.2 
No scan done 0 1  
Not diagnosed on scan 1 2  
Twin pregnancies* 5 (0.8) 12 (1.9) 0.14 
Mean GA at diagnosis (SD) 22w2d(6w4d) 18w0d(5w0d) 0.30 
Median 
Range 
20w1d 
16w1d–32w0d 
18w2d 
9w6d–26w3d 
 
Diagnosed < 24 weeks 3 (0.5) 11 (1.7) 0.20 
Placenta praevia* 1 (0.16) 1 (0.16) 1.00 
GA at diagnosis 20w1d 21w4d  
All complications* 14 (2.2) 19 (3.0) 0.47 
Mean GA at diagnosis (SD) 22w4d(4w4d) 19w1d(5w0d) 0.07 
Median 
Range 
Diagnosed < 24 weeks 
20w6d 
16w1d–32w0d 
8 
18w4d 
9w6d – 26w2d 
13 
 
 
0.5 
*: % of pregnancies with known outcome; w: weeks; d: days; SD: standard 
deviation  
 
Table 7 contains a summary of the IUD cases in both groups and indicates 
whether they received an ultrasound and if so at what GA. BW and GA at time of 
IUD were also noted. 
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Table 7 Summary of the intra-uterine death (IUD) cases in groups A and B 
Scan done at BW LGA/AGA/SGA GA at IUD Cause 
Group A     
No 2800g AGA 40w PE/CPI 
No 2600g SGA 40w CA 
No 4000g LGA 41w CA 
No 2600g SGA 40w Abruptio 
No 4170g LGA ? ? 
19w4d 2000g AGA 34w CA 
27w0d 2300g SGA 37w CPI/CA 
Group B     
No 1850g AGA 33 CA 
23w5d* 1620g AGA 30 ? 
31w5d 2360g SGA 39 CA 
17w1d 1760g SGA 38 CA/PlHypo 
20w5d 3800g AGA 40 CA 
22w1d 1400g SGA 33 CPI 
BW: birth weight; LGA: large for gestational age; AGA: appropriate for 
gestational age; SGA: small for gestational age; g: grams; w: weeks; d: days; 
PE: pre-eclampsia; CPI: chronic placental insufficiency; CA: chorio-amnionitis;  
?: uncertain; PlHypo: placental hypoperfusion; *: not confirmed IUD with 
ultrasound 
 
Table 8 describes the ultrasound examinations for both groups. The category 
before 18 weeks includes all cases with negative fetal heart action as identified 
by ultrasound, miscarriages, ectopic pregnancy, TOP and cases where no 
pregnancy was identified with ultrasound and who were later confirmed not to be 
pregnant. Of the 629 patients with known pregnancy outcome in Group B, 492 
(78.2%) attended the ultrasound department within 7 days of booking. 
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Table 8 Number and timing of ultrasound examinations in groups A and B 
 Group A  Group B  p  OR (95%CI) 
Women recruited 750 750   
Pregnancies with 
known outcome 
631 
(84.1)@ 
629 
(83.9)@ 
0.94  
Scans / patient* 
  Median (range) 
  Mean (SD) 
 
1 (0 – 11) 
0.81 (0.91) 
 
1 (0 – 12) 
1.41 (1.04) 
 
<0.001 
 
Women scanned 18-24w* 330 (52.3) 382 (60.7) 0.003 0.71 (0.56–0.89) 
Women scanned < 24 w* 336 (53.2) 412 (65.5) <0.001 0.60 (0.47–0.76) 
Women scanned at least 
once* 
390 (61.8) 567 (90.1) <0.001 0.18 (0.13–0.24) 
Of women scanned     
Not pregnant^ 3  9  0.14  
1st scan < 18w0d^ 44 (11.3) 233 (41.1) <0.001 0.13 (0.09–0.18) 
1st scan 18 - 24w^ 292 (74.9) 179 (31.6) <0.001 2.17 (1.70–2.75) 
1st scan < 24w0d^ 336 (86.2) 412 (72.7) <0.001 3.28 (2.32–4.63) 
1st scan ≥ 24w0d^ 51 (13.1) 146 (25.7) <0.001  0.29 (0.20–0.41) 
Any scan 18 - 24w^ 330 (84.6) 382 (67.4) <0.001 2.66 (1.90–3.74) 
Number of scans 512  890   
Of scans performed     
Not pregnant 4  9 0.14  
N < 18w0d$ 46 (9.0) 245 (27.5) <0.001 0.38 (0.29–0.50) 
N 18 – 24w$ 353 (68.9) 392 (44.0) <0.001 2.82 (2.23–3.51) 
N ≥ 24w0d$ 109 (21.3) 244 (27.4) 0.013 0.72 (0.55–0.93) 
OR: Odds ratio; CI: Confidence intervals; SD: standard deviation; @: % of 
patients recruited; *: % of pregnancies with known outcome; ^: % of women 
receiving at least 1 scan; $: % of total number of scans 
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Table 9 contains a summary of the reasons for requested follow-up 
examinations. These are only cases who received follow-up appointments at the 
ultrasound departments and do not include the cases who developed clinical 
reasons for ultrasound referral. Patients were given follow-up dates for dating if 
the pregnancy was found to less than 7 weeks GA and proper dating by 
ultrasound was not possible. 
 
Table 9 Reasons for requested follow-up ultrasound examinations for 
groups A and B 
Number (%) Group A  Group B  p-value OR (95% CI) 
Total requests 105 
(20.5)@  
(16.6)* 
313 
(35.2)@ 
(49.8)* 
 
<0.001 
<0.001 
 
0.48 (0.37– 0.62) 
0.20 (0.15 – 0.26) 
Patients attending for 
follow-up^ 
93 (88.6) 289 (92.3) 0.32  
Dating^ 0 (0) 9 (2.9) 0.12  
Gynaecology^ 2 (1.9) 1 (0) 0.16  
Fetal detail^ 42 (40.0) 212 (67.7) <0.001 0.32 (0.20 – 0.51) 
Possible fetal 
abnormality^ 
14 (13.3) 11 (3.5) <0.001 4.22 (1.73 – 10.38) 
Fetal growth and 
Doppler^ 
29 (27.6) 54 (17.3) 0.03 1.83 (1.05 – 3.17) 
Placenta localization^ 10 (9.5) 10 (3.2) 0.02 3.19 (1.19 – 8.58) 
Liquor volume^ 4 (3.8) 4 (1.3) 0.11  
Twin pregnancy^ 5 (4.8) 12 (3.8) 0.77  
OR: odds ratio; CI: confidence intervals; @: % of total number of scans; *: % of 
pregnancies with known outcome; ^: % of total number of requests 
 
A summary of the clinical reasons that developed as an indication for ultrasound 
referral to TBH is shown in Table 10. These referrals were made by the nursing 
staff following clinical assessment. 
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Table 10 Clinical reasons for ultrasound referral for groups A and B 
 Group A  Group B  p - value 
Total number of referrals* 29 (4.6) 34 (5.4) 0.60 
Fetal growth^ 21 (72.4) 22 (64.7) 0.70 
Liquor^ 2 (6.9) 5 (14.7) 0.44 
Fetal growth & Doppler^ 5 (17.2) 5 (14.7) 1.00 
Placenta localization^ 1 (3.4) 0 (0) 0.46 
Fetal presentation^ 0 (0) 2 (5.9) 0.50 
*: % of patients with known pregnancy outcome; ^: % of total number of referrals 
 
Table 11 contains information on place of birth, labour and mode of delivery. 
Some patients delivered elsewhere and were telephonically contacted to collect 
the information. Cases of IUD in both groups and maternal death in Group B 
were included. Cases of TOP were not included. The referral policy for high risk 
patients changed during the course of the study. Where patients in certain high 
risk categories requiring level I care were previously referred to TBH, they were 
referred to KBH. 
 
The maternal death in Group A occurred at 26 weeks 3 days GA. The baby died 
intra-uterine. The patient received scans at Bishop Lavis CHC and TBH with 
unilateral talipes suspected at Bishop Lavis CHC, diagnosed as bilateral talipes 
at TBH. Cause of death was acute respiratory distress and the patient had 
tuberculosis. The maternal death in the Group B occurred during birth, the baby 
was a breech delivery. The patient collapsed unexpectedly following the delivery 
with respiratory distress and subsequent cardiac arrest. The patient could not be 
resuscitated. The patient did not have a postpartum haemorrhage. The most 
likely cause of death was pulmonary embolism. The patient did not have an 
autopsy. The baby was healthy. One set of twins in Group B was diagnosed at 
26 weeks and 3 days, however one of the fetuses did not have a positive fetal 
heart action. 
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In the one case of ENND in Group A the patient did not receive an antenatal 
ultrasound. The baby was born at 26 weeks GA and died 2 days later. The 
primary cause of death was stated to be congenital syphilis and the final cause 
of death as severe prematurity. In the one case of ENND in Group B the patient 
also did not receive an antenatal ultrasound and delivered at 39 weeks 2 days 
GA according to FH.  The 5 minute Apgar score was 3. The baby was born with 
a renal abnormality and died on day 1. 
 
Table 11 Place of birth, labour and mode of delivery for groups A and B. 
*: % of number of deliveries; E/R: Elsiesriver; MOU: midwife 
obstetric unit; TBH: Tygerberg hospital; KBH: Karl Bremer hospital; 
BBA: birth before arrival 
 Group A Group B p-value 
Number of deliveries 618 605  
Place of birth:  E/R MOU 317 (51.3)* 332 (54.9)* 0.23 
                        TBH 261 (42.0)* 158 (26.1)*  
                        KBH 21 (3.4)* 101 (16.7)*  
                        TBH + KBH 282 (45.4)* 259 (42.8)* 0.35 
                        BBA 17 (2.7)* 12 (2.0)* 0.49 
                        Other 2 (0.3)* 2 (0.3)* 1.00 
Labour:  Spontaneous 522 (84.4)* 517 (85.5)* 0.91 
              Induced 72 (11.7)* 72 (11.9)* 0.96 
Elective caesarean section 24 (3.9)* 16 (2.6)* 0.30 
Mode of delivery:  Vaginal 535 (86.6)* 528 (87.3)* 0.78 
                             Caesarean section^ 83 (13.4)* 77 (12.7)* 0.78 
^: Including the elective caesarean sections 
 
Table 12 contains the reasons for induction of labour and caesarean sections for 
both groups and Table 13 describes the complications that would be affected by 
inaccuracies in GA determination (postdates and preterm deliveries, small-for-
gestational age fetuses). 
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Table 12 Reasons for induction of labour and caesarean sections for groups A 
and B 
N (%) Group A  Group B  p OR (95%CI) 
Women delivered 618 605   
Induction of labour* 72 (11.7) 72 (11.9) 0.96  
Postdates^ 16 (22.2) 8 (11.1) 0.12  
IUD^ 5 (6.9) 4 (5.6) 1.00  
SROM ^ 29 (40.3) 32 (44.4) 0.74  
PIH^ 7 (9.7) 5 (6.9) 0.74  
PE^ 6 (8.3) 20 (27.8) 0.004 0.24 (0.08–0.68) 
GDM^ 1 (1.4) 1 (1.4) 1.00  
Other^ 8 (11.1) 2 (2.8) 0.10  
Caesarean section* 83 (13.4) 77(12.7) 0.78  
Fetal distress$ 39 (47.0) 26(33.8) 0.15  
Breech presentation$ 8 (9.6) 11(14.3) 0.61  
Poor progress$ 15 (18.1) 20(26.0) 0.31  
Failed induction$ 5 (6.0) 8(10.4) 0.55  
Elective$ 10 (12.0) 8(10.4) 0.85  
Other$ 6 (7.2) 4(5.2) 0.75  
OR: odds ratio; CI: confidence intervals; *: % of women delivered; ^: % of labour 
inductions; $: % of number of caesarean sections; IUD: intrauterine death; 
SROM: spontaneous rupture of membranes; PIH: pregnancy induced 
hypertension; PE: pre-eclampsia; GDM: gestational diabetes mellitus
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Table 13 Post-dates deliveries (≥42 weeks), preterm deliveries (< 37 weeks) 
and SGA infants (less than 10th centile for gestation) for groups A and B, 
categorised according to the timing of the ultrasound examination 
 Group A Group B p   OR (95%CI) 
Post-dates deliveries^ 81 (13.1) 51 (8.4) 0.01 1.64 (1.11–2.41) 
    Scan < 24 weeks^ 19 (3.1) 18 (2.9) 0.95  
    Scan ≥ 24 weeks^ 11 (1.8) 23 (3.8) 0.032 0.46 (0.21-0.99) 
    No scan^ 51 (8.3) 10 (1.6) <0.001 5.35 (2.60-11.34) 
    No scan < 24 weeks^ 62 33 0.003 1.32 (1.13-1.55) 
Preterm deliveries^ 96 (15.5) 101 (16.7) 0.64  
    Scan < 24 weeks^ 41 (6.6) 49 (8.1) 0.38  
    Scan ≥ 24 weeks^ 8 (1.3) 36 (6.0) <0.001 0.21 (0.09–0.47) 
    No scan^ 47 (7.6) 16 (2.6) <0.001 3.03 (1.65–5.64) 
    No scan < 24 weeks^  55 52 0.93  
Pregnancies with 
SGA^ 
52 (8.4) 60 (9.9) 0.42  
    Scan < 24 weeks^ 39 (6.3) 46 (7.6) 0.44  
    Scan ≥ 24 weeks^ 3 (0.5) 10 (1.7) 0.09  
    No scan^ 10 (1.6) 4 (0.7) 0.19  
   No scan < 24 weeks^ 13 14 0.8  
SGA infants  54 63   
   Singleton alive 47 46   
   1 of twin alive 3 8   
   2 of twins alive 4 6   
   Singleton iud 0 3   
Total complications 
related to dating^ 
229 (37.1) 212 (35.0) 0.50  
    Scan < 24 weeks^ 99 (16.0) 113 (18.7) 0.25  
    Scan ≥ 24 weeks^ 22 (3.6) 69 (11.4) <0.001 0.29 (0.17–0.48) 
    No scan^ 108 (17.5) 30 (5.0) <0.001 4.06 (2.61–6.33) 
    No scan < 24 weeks^ 130 99 0.043 1.36 (1.01-1.84) 
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^: % of number of deliveries; *: % of live births; SGA: small for gestational age; 
IUD: intra-uterine death 
 
The two groups were compared in order to determine the impact of ultrasound at 
or after 24 weeks 0 days with regard to the percentage of suspected postdates 
deliveries. The number of suspected postdates cases in Group A patients who 
did not receive an ultrasound (51) was significantly higher than suspected 
postdates cases in Group B patients who received an ultrasound at or after 24 
weeks 0 days GA (23).  [p = 0.001 (OR -95% CI) 2.28 (1.34 – 3.89)]. 
 
The same calculations were performed on the preterm deliveries as well as the 
SGA cases. The number of preterm delivery cases in Group A who did not 
receive an ultrasound (47) was not different from the number of preterm delivery 
cases in Group B who received a scan at or after 24 weeks GA (36) (p = 0.30). 
 
The number of pregnancies with SGA babies in Group A patients who did not 
receive an ultrasound (10) was not different from patients in Group B who 
received an ultrasound at and after 24 weeks GA (10) (p = 0.86). In order to 
determine the impact of ultrasound at or after 24 weeks GA on the total number 
of complications related to the accurate dating of pregnancies, the number of 
cases in Group A patients who did not receive an ultrasound (108) was 
significantly higher than in Group B patients who received a scan at or after 24 
weeks GA (69) [p = 0.003 OR (95%CI): 1.65 (1.17 – 2.31)]. 
 
There were 354 (56.1%) patients in Group A and 313 (49.8%) patients in Group 
B who were sure about the date of their LMP. This difference was statistically 
significantly different [p = 0.03; OR (95%CI): 1.29 (1.03 – 1.62)]. Comparing only 
FH measurement at booking, the mean GA as determined by FH measurement 
showed a trend towards a statistical difference (24.50 weeks SD 4.89 vs. 25.17 
weeks SD 4.99, p = 0.05). Clinically determined GA at the booking visit (based 
on information from LMP and FH combined) was 21.63 weeks SD 6.20 for group 
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A and 22.64 SD 6.48 for group B (p = 0.01). Four hundred and forty four patients 
in Group B attended their ultrasound appointment within 7 days of booking. The 
average clinical GA of these patients prior to ultrasound (22.35 weeks SD 6.21) 
was not different from after ultrasound (21.72 weeks SD 6.14)(p = 0.14) but in 
135 patients (30.4%) the difference between ultrasound dating and clinical 
dating was 3 weeks or more and in 81 (18.3%) the difference was even 4 weeks 
or more. Overestimations of 3 weeks or more (84) were significantly more 
common than underestimations of 3 weeks or more (51) [p = 0.002, OR (95%CI) 
1.80 (1.21-2.67)]. 
 
Ultrasound, LMP dates and FH were compared in order to determine which 
method predicts the date of delivery most accurately. The two groups were 
combined and 218 patients had sure LMP dates, received an ultrasound (at any 
GA), had a known FH measurement prior to ultrasound, had a spontaneous 
onset of labour and normal BW.  FH resulted in an average GA of 39.8 weeks 
(SD: 3.21), ultrasound in 39.1 weeks GA (SD: 1.93) and LMP dates in 38.5 
weeks GA (SD: 3.21). A statistically significant difference was found between all 
three groups with p – values of 0.02, 0.01 and < 0.001 when comparing 
ultrasound with LMP dates, ultrasound with FH and LMP dates with FH 
respectively. Table 14 contains a summary and comparison of the number and 
percentage of patients with the difference between the EDD as determined by 
the three dating methods and the actual date of birth. 
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Table 14 Number (%) of patients with difference (in days) between expected 
date of delivery predicted according to the three dating methods 
(Ultrasound, LMP and FH) and actual date of birth, calculated in 
218 patients with data on all 3 parameters 
Difference U/S LMP FH U/S vs 
LMP  
p–value  
U/S vs 
FH  
p–value  
LMP vs 
FH  
p–value  
0 – 3 119 (54.6) 143 (65.6) 53 (24.3) 0.02 <0.001 <0.001 
0 – 7 167 (76.6) 144 (66.1) 93 (42.7) 0.02 <0.001 <0.001 
0 – 10 196 (89.8) 145 (66.5) 119 (54.6) <0.001 <0.001 0.01 
> 10 22 (10.1) 73 (33.5) 99 (45.4) <0.001 <0.001 0.02 
U/S: ultrasound; LMP: last menstrual period, FH: fundal height 
 
Data from the two groups were combined to determine the impact of BMI on the 
accuracy of FH measurements. All patients who received an ultrasound and had 
a known FH measurement prior to the ultrasound were included in the 
calculation. The difference in weeks between GA as determined by ultrasound 
and FH was determined for the different BMI categories. In Figure 1 this 
difference is expressed as the percentage of cases agreeing within 3 weeks or 
less. 
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Figure 1 Percentage of patients with gestational age determined by 
ultrasound and fundal height differing by 3 weeks or less divided 
into categories by body mass index (BMI) 
45
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In order to determine booking tendencies, we evaluated the GA of 444 patients 
from Group B who received their ultrasound examination within 7 days of 
booking:  104 (23.4%) were found to be less than 18 weeks pregnant, 188 
(42.3%) between 18 weeks 0 days and 23 weeks 6 days and 152 (34.2%) 24 
weeks or more.  Therefore 65.7% of patients booked prior to 24 weeks GA and 
would have been eligible for a detailed scan. 
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Chapter 6 
 
DISCUSSION 
 
This study investigated the impact of expanding an obstetric ultrasound service 
from a policy of routinely providing a scan between 18 and 23 weeks 6 days with 
further scans offered for a selected list of clinical indications to a policy where an 
ultrasound examination within 7 days of booking is offered in addition. This 
would result in ultrasound examinations also being offered to women booking for 
antenatal care after 24 weeks gestation, who are not routinely offered a scan 
with the current protocol. The main finding of the study is that the booking scan 
protocol is associated with a 74% increase in total workload, but that this did not 
lead to improved pregnancy outcome or higher and/or earlier detection rates for 
congenital fetal abnormalities, twin pregnancies or placenta praevia.  
 
The selection of participants for our study differed from previous studies 
investigating different ultrasound protocols and services in the TBH drainage 
area.12,13  In the index study patients were excluded if they had any maternal 
medical condition or historical high risk factor that would require referral to the 
high risk clinics at KBH and TBH or the ultrasound unit at TBH. The results are 
therefore only applicable to low-risk patients. 
 
The two groups were comparable with regard to patient age, gravidity, parity and 
average birth weight and these findings were in concordance with results from 
other studies previously conducted in the TBH drainage area (Table 1).12,13 
There was no difference in the number of live births, miscarriages, terminations 
or perinatal losses. The non-significant difference in the number of miscarriages 
between the two groups can be explained by the higher early scanning rate in 
group B leading to 8 times as many findings of absent fetal heart action while in 
Group A most miscarriages were probably identified prior to the routine 
ultrasound examination, which was scheduled between 18 and 23 weeks GA. 
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Patients tend not to return to the antenatal clinic to report pregnancy losses and 
were therefore lost to follow-up. There was no difference in mean GA at delivery, 
proportion of babies with low birth weight or a 5 minute Apgar less than 7. The 
statistically significant difference in median 5 minute Apgar scores was probably 
a type one error and not of any clinical significance. There was no difference in 
type of labour and mode of delivery or reasons for caesarean section. The 
indications for induction of labour remained unchanged during the study apart 
from an unexplained increase in inductions for pre-eclampsia in group B. The 
proportion of patients who delivered at Elsiesriver CHC was comparable 
between the two groups (Table 11) in spite of rerouting of level I patients to KBH 
instead of TBH from 1st July 2008. The change in referral protocol during the 
study might be seen as a disadvantage of our study, however, since the 
proportion of patients delivering at Elsiesriver CHC was unchanged it would 
seem that it did not have a perceivable impact. 
 
Birth complications and fetal abnormalities:  No difference was found in the 
number of birth complications between the two groups (Table 3, p = 0.29). There 
were 14 congenital fetal abnormalities in total (1.1%) which is lower than 
accepted percentages of between 2 and 3% and a reflection of the low-risk 
nature of the cohort studied.3 One case in Group A and two cases in Group B 
were overlooked at the Bishop Lavis ultrasound department but the ultrasound 
equipment used at this facility during the study was approximately 9 years old 
with limited image quality. The incidence of Down’s syndrome was 1.6 per 1000 
live births and for congenital diaphragmatic hernia, spina bifida, cleft lip and 
palate and unilateral renal agenesis the incidence was 0.8 per 1000 which is in 
concordance with published data.3,41 For talipes the incidence was 4 per 1000 
which is twice as high as the published data of 1 to 2 per 1000 births.3 Talipes 
shows multifactorial inheritance with both genetic and environmental factors 
playing a role. The reason for the increased incidence in our study population is 
uncertain but may be a chance finding. The introduction of a booking scan 
protocol did not result in a higher number of fetal abnormalities being detected 
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or an earlier average GA at diagnosis. Significantly more of follow-up scans 
were requested because of possible fetal structural abnormalities in Group A 
(Table 9; p < 0.001) but this is merely a reflection of a much higher number of 
follow-ups for other reasons in Group B since the difference is not significant 
when compared to the total number of patients scanned. 
 
Twins:  There were 16 (1.3%) twin pregnancies, an incidence which is in 
concordance with the literature of approximately 1%.3 There were more than 
twice as many twin pregnancies in Group B than in Group A but this was not 
significant and the reason for this is uncertain (Table 1). All cases in both groups 
were known prior to birth and the difference in average GA at diagnosis of the 
twin pregnancies, albeit four weeks earlier in Group B, was not statistically 
significant due to small numbers. In the clinical setting however, four weeks 
could make a difference in the correct diagnosis of chorionicity as the ultrasound 
features disappear with advancing GA or in the recognition of early 
complications in MC twins. 
 
The average GA of diagnosis of fetal abnormalities, twin pregnancies and 
placenta praevia was regarded as one entity for both groups and was not 
statistically different (p = 0.07), demonstrating no benefit  of a booking scan 
policy in earlier  diagnosis of these pregnancy complications. The numbers are 
however very small and influenced by a significant outlier in group A (twins 
detected at 32 weeks). The % of complications detected before 24 weeks was 
not different. 
 
At the time when the sample size for this study was determined, the referral rate 
from the ultrasound unit at Bishop Lavis CHC to TBH was used. However, the 
10% referral rate included patients who were referred for the detection of single 
soft markers for chromosomal abnormalities. Between the writing of the protocol 
and the start of the study, this unwarranted referral policy was ended. This 
resulted in a drop in referral rate to approximately 5.4%. We also presumed a 
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scan rate of approximately 40% in Group A and a 90% scan rate in Group B. 
The scan rate in Group A was in fact 61.8% and in 90.1% in Group B. These 
factors attributed to the fact that the presumed detection rate prior to and after 
the change in policy were not reached in groups A and B respectively. 
 
Postdates deliveries:  The incidence of postdates pregnancies (10.8%) in our 
study was in concordance with a previous study conducted on a similar 
population in the TBH drainage area.13 There were significantly more suspected 
postdates pregnancies in Group A (p = 0.01) resulting from a significant 
difference in the women who were not scanned (Table 13; p < 0.001). The 
introduction of a booking scan for all women reduced the incidence of suspected 
postdates pregnancies in Group B as a whole and in the sub-group who 
received an ultrasound at or after 24 weeks 0 days GA. This is probably due to 
more accurate GA determination with ultrasound, both before and after 24 
weeks 0 days GA. 
 
Preterm deliveries:  A previous study performed on a similar population 
demonstrated the same incidence of preterm deliveries as in our study 
(16.1%).13 The two groups, as well as the subgroups who were scanned before 
24 weeks GA, were comparable with regard to the percentage of preterm 
deliveries but a significant difference was found in the women who were 
scanned at or after 24 weeks GA (Table 13; p < 0.001) and in those who did not 
receive an ultrasound (p < 0.001). There was no difference between patients in 
Group A who were not scanned and patients in Group B who received a scan at 
and after 24 weeks (p = 0.30). This would indicate that performing an ultrasound 
at and after 24 weeks GA does not reduce the number of perceived preterm 
deliveries when compared to not performing a scan at all. 
 
SGA: The incidence of SGA babies (9.6%) in our study was comparable with a 
previous study conducted on a similar population in the TBH drainage area.12 No 
significant difference was found between the two groups with regard to the 
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percentage of SGA cases, both in the groups as a whole or the subgroups of 
women who had a scan before or after 24 weeks or women who had no 
ultrasound examination. The introduction of a booking scan regardless of GA did 
not change the incidence of infants being regarded as SGA. 
 
The number of suspected postdates deliveries, preterm deliveries and SGA 
cases in the sub-groups who received ultrasound examinations before 24 weeks 
GA as well as the overall incidence of low birth weight babies in both groups 
being no different indicates that the population did not change from the first to 
the second time period. 
 
Postdates deliveries, preterm deliveries and SGA cases are all complications 
that could be influenced by inaccuracies in the dating of pregnancies. When 
grouped together the impact of ultrasound at and after 24 weeks was 
determined by comparing patients in Group A who were not scanned to patients 
in Group B who received a scan at and after 24 weeks GA. This yielded a 
significant difference (p = 0.003) which was mainly due to the big impact of late 
ultrasound on the incidence of suspected postdates delivery. 
 
IUD:  The incidence of IUD after 27 weeks in this study was 1.1% and the 
introduction of a booking scan protocol did not reduce this, which is in line with 
the literature.42 No difference was found when comparing the percentage of IUD 
cases who received an ultrasound in the two groups and since the predominant 
cause of death was chorio-amnionitis the demise could not have been expected 
to be prevented by an ultrasound examination. Almost half of the babies born in 
the IUD cases were SGA which would reflect the accompanying chronic 
placental insufficiency. 
 
Ultrasound exposure and workload:  Significantly more patients (p < 0.001) 
had at least one scan in Group B (Table 8). In Group A 61.8% of patients 
received at least 1 scan and an average of 0.81 scans was performed per 
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booked patient. With a booking scan for all women regardless of GA and follow-
up scan for selective clinical indications 90.1% of patients received at least 1 
scan and an average of 1.41 scans were performed per booked patient. 
Therefore when comparing the two protocols per 100 booked patients, 28 more 
patients would receive at least one scan and 60 extra scans would need to be 
performed in total with the new protocol. 
 
The booking scan policy significantly increased the number of patients receiving 
their first ultrasound examination before 24 weeks GA (8% increase, p < 0.001) 
and a detailed scan between 18 and 23 weeks 6 days GA (12% increase, p = 
0.003) (Table 8). This could be due to more accurate early pregnancy dating in 
Group B with resultant more accurate timing of detailed scans. The GA period 
between 18 and 23 weeks is regarded as the most opportune time to perform a 
detailed scan and detect fetal abnormalities. 
 
There was a significant (p < 0.001) increase in the number of follow-up scans 
requested as well as in the total number of scans performed in Group B (Tables 
9 and 10). The increased number of follow-up scans is mainly due to the higher 
scanning rate prior to 18 weeks with subsequent request for follow-up detailed 
scans. The significant differences in the proportion of follow-ups requested for 
low-lying placenta and fetal growth and Doppler (Table 9) are merely a reflection 
of more follow-ups for other reasons in Group B since they became non-
significant when follow-ups for routine detailed scans were excluded. 
 
Dating:  Only about half of patients were sure about the date of their LMP, this 
is similar to observations by other authors working in developing countries.7,25 
Statistically significant differences in GA at spontaneous onset of labour were 
found when the 3 pregnancy dating methods (FH, ultrasound and LMP) were 
compared. Determining the predictive value for the EDD of each of the dating 
methods revealed that ultrasound performed significantly better than LMP and 
FH measurement (Table 14). Ultrasound predicted the EDD within 10 days in 
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89.8% of cases while LMP and FH predicted this in only 66.5% and 54.5% of 
cases respectively and all these percentages were significantly different from 
one another. Four hundred and forty four patients in Group B were scanned 
within 7 days of booking and although their average GA before and after 
ultrasound was comparable, this difference was 3 weeks or more in 135 patients 
(30.4%) and 4 weeks or more in 81 (18.3%) and serious overestimations were 
significantly more common than underestimations [p = 0.002, OR (95%CI) 1.80 
(1.21-2.67)]. 
 
BMI and FH:  A small (0.51) but statistically significant difference in BMI was 
found between the two groups but this is probably a type one error and not of 
clinical significance. GA by FH agreed with ultrasound within 3 weeks in 75 to 
80% of cases with a BMI up to 39.9 kg/m2. This agreement fell to approximately 
46% in cases with BMI equal or greater than 40 kg/m2 (Figure 1). Although the 
results of the study may not support the implementation of a protocol with 
booking scans in all women, in cases with a BMI of 40 kg/m2 or greater a 
booking scan may be recommended for dating purposes as there is poor 
agreement between FH and fetal size as determined by ultrasound. 
 
Booking tendencies:  Booking tendencies were determined in patients from 
Group B who were scanned within 7 days of booking: 23.4% of patients booked 
prior to 18 weeks GA, 42.3% between 18 weeks 0 days and 24 weeks GA and 
34.2% booked at or after 24 weeks 0 days GA. This indicates that approximately 
66% of patients were eligible for a detail scan before 24 weeks and it is unclear 
therefore why only 53% of patients in group A received a detailed scan before 
24 weeks according to the existing policy. A possible explanation is the 
systematic serious overestimation of the GA (with more than 3 weeks) by clinical 
methods (LMP combined with FH) in 19% of patients, which would lead to non-
referral in a number of women who are truly less than 24 weeks pregnant. An 
alternative explanation would be the non-attendance for ultrasound 
appointments, which occurred for approximately 22% of booking scans in group 
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B. In view of the coinciding of the festive season, group A may have been at 
some disadvantage in this regard since appointments were not available on 
public holidays and non-attendance may have been higher. Even if this had 
been a source of potential bias though, the results of the study would not have 
been different since the current results do not show overall benefit of a booking 
scan policy. 
 
The reasons for this lack of overall benefit are multiple. Since 66% of patients 
booked before 24 weeks, only 34% of women could have benefited from an 
additional booking scan and this small number may have limited the potential of 
this study to show the benefits of booking scans. It is questionable whether the 
additional work load of booking scans justifies the small gains in cohorts with 
similar patient characteristics as the index study but in communities where fewer 
women book before 24 weeks, a booking scan policy may be of greater benefit. 
The fact that 22% of women did not attend for the booking scan appointment 
may also have limited the impact of the new protocol and this puts in question 
the utilisation of available services by the patients. Currently a single 
ultrasonographer at the Bishop Lavis CHC serves 5 primary care antenatal 
clinics in the TBH drainage area. Patients from 4 of these clinics need to travel 
some distance to receive their ultrasound examinations (Elsiesriver and Bellville 
South CHC are located approximately 6 and 11 kilometres away). Most patients 
rely on public transport which may be infrequent and many patients are socio-
economically deprived and not able to afford the travelling costs involved. 
Different results might therefore have been obtained if the ultrasound service 
had coincided with the booking clinic in each facility. 
 
 73 
Chapter 7 
 
CONCLUSION 
 
The two groups were comparable with regard to baseline data and site of 
delivery supporting the assumption that the study population did not change 
between the two periods in spite of a change in referral pattern for certain high 
risk patients. 
 
No difference in any of the pregnancy outcome parameters was found between 
the two groups. The booking scan protocol did not affect the number of infants 
considered to be SGA at birth, nor the number of fetal abnormalities, twins or 
placenta praevia detected prior to delivery. It did not significantly affect the GA at 
which the fetal abnormalities and twins were detected but caused a significant 
reduction in suspected postdates pregnancies not only for the whole group but 
especially in the sub-group that was scanned at and after 24 weeks GA. This 
would prevent unnecessary referrals to level II and III facilities for fetal 
surveillance because of suspected postdates pregnancies. No difference was 
found in the number of birth complications between the two groups. This was 
expected as the booking scan protocol did not result in the detection of 
significantly more problems that would have altered antenatal management and 
improved the outcome. 
 
The three pregnancy dating methods (FH measurement, ultrasound and LMP 
dates) were found to be significantly different. Ultrasound predicted the EDD 
within 10 days in significantly more cases than LMP or FH measurements and 
FH performed significantly worse than LMP. In the large majority (75-80%) of 
women with BMI less than 40 kg/m2, the estimated GA as determined by FH and 
ultrasound agreed with 3 weeks but with higher BMI the agreement fell under 
50%. A high BMI would therefore in our opinion justify a booking scan for dating.  
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The booking scan protocol increased exposure of patients to ultrasound but the 
associated 74% increase in total workload did not result in clinical benefit and is 
in our opinion not justified. Possible reasons for the negative findings in this 
study were the high rate of booking before 24 weeks (66%) and non-attendance 
(22%). It may therefore still be worthwhile to investigate the value of a booking 
scan protocol in a population where more patients book after 23 weeks GA, 
where the incidence of obesity is higher or where the scan is offered in the clinic 
and on the day of booking itself. 
 
 
RECOMMENDATIONS 
 
Most populations in the Tygerberg drainage area are socio-economically 
deprived and travelling costs can be a barrier to adherence to appointments. A 
travelling ultrasonographer who visits antenatal clinics with good quality portable 
equipment could help to improve patients’ access to ultrasound services by 
avoiding travel to centrally located ultrasound department. 
 
Since very few women in the study population recall the first day of their LMP 
with accuracy (only 50% recall the date), FH is often relied upon to estimate GA. 
While FH seems to be fairly accurate in a large proportion of leaner women, its 
agreement with ultrasound is too poor to be clinically useful in patients with a 
BMI of 40 kg/m2 or more. A booking scan for these obese women would aid 
substantially in determining GA more accurately and should therefore be 
supported. Since even in leaner women, the clinical dating methods are much 
more likely to overestimate the true GA than to underestimate it, it may also be 
of benefit to increase the cut-off value of FH for offering a detailed scan to 
possibly 26 cm instead of the current 23 cm. 
 
A combination of both protocols is likely to be more cost-effective: patients 
booking with a FH of less than 26 cm are scheduled for a detailed scan between 
18 and 24 weeks clinically estimated GA while patients booking later than this 
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(either all of them or at least those with a BMI of 40 kg/m2 or more) are scanned 
as soon as possible after booking. This protocol would probably still 
demonstrate the benefit of reduced postdates pregnancies while significantly 
reducing the total workload. This could be the topic of a subsequent study. 
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APPENDIX A 
 
ULTRASOUND DEPARTMENT 
BISHOP LAVIS COMMUNITY HEALTH CENTRE 
 
REFFERAL PROTOCOL 
Effective from 09/07/2007 
 No dating scans 
 Refer for a detail scan between 18 weeks 0 days and 23 weeks 6 days 
(Preferably at 21 weeks) SF=18 to 23cm 
 Increased SF at 2nd or subsequent visits or after an ultrasound (? 
twins, ? Polyhydramnios) 
 Patients with chronic hypertension, controlled with one drug and 
patients with pregnancy induced hypertension, <34weeks, diastolic 
<110 mmHg, controlled with one drug: 
 Detail scan between 18 and 23 weeks 6 days 
 Doppler examination at 24 weeks (no earlier) or as soon as 
possible after booking in cases of late bookers 
 Patients who conceived when 37 years of age or older should be 
referred directly to Tygerberg Hospital for genetic counseling (Tel: 
021 938 5572) 
Make an appointment for: 
 Nuchal Translucency scan between 11 and 13 weeks 6 days 
 Genetic counseling at 16 weeks 
 Decreased SF measurement at 2nd or subsequent visits or after an 
ultrasound (? IUGR) = Refer to Fetal Evaluation Clinic (FEC) at 
Tygerberg Hospital with a FEC referral letter. 
Kind Regards                                                                                                    
Sonographer, Bishop Lavis Community Health Center                                          
021 934 6127 
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APPENDIX B 
 
Fundal height centile chart for the Tygerberg region 
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APPENDIX C 
 
CORRECT USE OF THE NEW SYMPHYSIS-FUNDUS CURVE 
The new curve was compiled using women in the Tygerberg Hospital drainage area.  
The curve is easily recognizable as it starts at 18 weeks and continues until 42 weeks 
gestational age.  The previous curve that was compiled in Argentina starts at 20 weeks 
and continues until 40 weeks.  
 
HOW DOES UTRERINE SIZE COMPARE TO GESTATIONAL AGE? 
1. Up to 12 weeks uterine size can reasonably accurately be determined with a 
bimanual examination.  If there is uncertainty about gestational age before 12 
weeks the patient should be examined bimanually by a doctor. 
2. Between 13 and 17 weeks the abdominal examination is the more accurate 
method to determine gestational age.  The fundal height is more than 2 
fingers below the umbilicus.   
3. From 18 weeks onwards symphysis-fundus measurement is the more 
accurate measurement.  The fundal height is 2 fingers below the umbilicus or 
higher. 
 
HOW MUST GESTATIONAL AGE BE DETERMINED IF THE UTERINE SIZE 
DIFFERS FROM THE GESTATIONAL AGE AS DETERMINED BY USING 
THE LAST NORMAL MENSTRUAL PERIOD? 
1. With the fundal height below the umbilicus (less than 22 weeks pregnant): 
i) With a difference of 3 weeks and more the uterine size must be used 
as the more likely correct gestational age. 
ii) With a difference of less than 3 weeks the last menstrual period must 
be used as the more likely correct gestational age. 
 
2. With the fundul height at the height of the umbilicus or higher (22 weeks 
pregnant or more): 
i) With a difference of 4 weeks and more the uterine size must be used 
as the more likely correct gestational age. 
ii) With a difference of less than 4 weeks the last menstrual period must 
be used as the more likely correct gestational age. 
 
HOW MUST THE SF-MEASUREMENT BE USED TO DETERMINE 
GESTATIONAL AGE? 
The SF-height in centimeters on the 50
th
 centile from 18 to 42 weeks is used to 
determine gestational age in weeks.  A SF-measurement of 26cm corresponds to a 
gestational age of 27 weeks. 
 
A DIFFERENCE BETWEEN UTERINE SIZE AND GESTATIONAL AGE AS 
DETERMINED BY THE LAST NORMAL MENSTRUAL PERIOD IS MOST 
LIKELY THE RESULT OF INCORRECT DATES 
 
GB Theron 
